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1. The rat uterus varies in its response to adrenoceptor 
agonists throughout the oestrous cycle, and the 
mechanisms underlying this variation have been investigated 
using pharmacological and biochemical techniques.
2. Acetylcholine (ACh) and potassium chloride (KCI) were 
used to raise tone in isolated uterine horn preparations. 
Both motor agents produced the highest tension in oestrus 
and this effect may reflect changes in thickness of the 
myometrium during the oestrous cycle.
3. The three adrenoceptor agonists studied, noradrenaline 
(NA), adrenaline (ADR) and salbutamol (SAL) produced 
inhibitory responses throughout the oestrous cycle.
However, the maximum degree of inhibition achieved by 
each agonist varied in the four phases.
4. Stimulation of a-excitatory adrenoceptors contributed 
to the variation seen with NA and ADR (which possess 
a-adrenoceptor activity), but could not explain that 
of SAL , a selective P^-B^^G^oceptor agonist.
5« Blockade of agonist uptake processes into neuronal and 
extraneuronal sites, enhanced the inhibitory responses 
produced by NA, ADR and SAL, indicating a role for the 
removal mechanisms in the observed variation in response.
6. The variation in agonists responses persisted even when 
the contribution of both a-adrenoceptors and the uptake 
processes were controlled , suggesting that other factors 
could be involved.
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7« Ovarian hormones appeared to play a major role in the 
variation since responses to NA, ADR and SAL were 
enhanced in uteri from ovariectomized rats.
8. Intramural prostaglandin generation was involved in the 
responses to the adrenoceptor agonists, since cyclo- 
oxygenase inhibition, i.e., block of prostaglandin 
formation, enhanced the inhibition produced by NA , ADR 
and SAL. The effect was specific to the adrenoceptor 
agonists because the inhibitory responses to histamine 
and papaverine were unaffected by eyelo-oxygenase 
inhibition.
9* The leukotrienes are not involved in the adrenoceptor 
agonists responses, since inhibition of both cyclo- 
oxygenase and lipoxygenase produced effects similar to 
blocking the eyelo-oxygenase pathway alone.
10. Biochemical measurements of uterine adenosine 3'»5' 
cyclic monophosphate (cAMP) were made throughout the 
oestrous cycle. Basal cAMP levels were similar in 
proestrus, oestrus, metoestrus and dioestrus.
11. cAMP did not appear to be involved in the variation in 
uterine response to adrenoceptor agonists because SAL- 
induced increases in cAMP levels were similar in all
four phases of the oestrous cycle. Intramurally generated 
prostaglandins have no effect on cAMP formation, since 
cyclo-oxygenase inhibition was without effect on cAMP 
levels.
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12. Calcium movements were studied in uteri from both 
intact and ovariectomized rats using radioactive 
calcium (^^Ca^*). ^^Ca^* influx and efflux varied
in the different hormonal conditions of the oestrous 
cycle, and in the absence of the hormones, following 
ovariectomy.
2+13» SAL had no effect on Ca influx and efflux,
indicating that the adrenoceptor agonists inhibitory 
responses in the rat uterus could involve an increased 
intracellular binding of calcium. 
l4. The variation in uterine response to the adrenoceptor 
agonists during the oestrous cycle is due, therefore, 
to the combined effects of a-adrenoceptor activity, 
agonist removal processes, intramurally generated 
prostaglandins and the ovarian hormones. Of these^ 
the factors of major importance are the prostaglandins 
and the ovarian hormones.
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ABBREVIATIONS
ACh Acetylcholine
ADR Adrenaline
AZA Azapetine
BW 755c 3-amino-l-(m-trifluoromethyl)-phenyl-2-pyrazolone
45 2+Ca Radioactive calcium
cAMP Adenosine 3 ’3 ’ cyclic monophosphate
DMI Desmethylimipramine
EC^Q Concentration producing ^0% of the maximum response
EDTA Ethylene diamine tetra-acetic acid
FBF Flurbiprofen
HIS Histamine
NA Noradrenaline
PAP Papaverine
pD^ Negative logarithm to the base 10 of the EC^^
SAL Salbutamol
TCA Trichloroacetic acid.
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RAT UTERUS
A. ANATOMICAL AND PHYSIOLOGICAL CONSIDERATIONS
Rats possess a bicornate uterus with the two horns 
maintaining separate openings into the vagina. The uterus 
consists of an outer myométrial layer which is lined by an 
inner glandular mucosa called the endometrium. The myométrial 
layer contains an outer longitudinal and an inner circular 
muscle layer, separated by a well defined band of connective 
tissue (Bengtsson^ 1982). The cyclical production of 
oestrogen and progesterone by the ovaries results in an 
oestrous cycle lasting between four to five days (Hogarth , 
1978). Yoshinaga, Hawkins and Stocker (1969) showed that 
the oestrogen secretion rate began to rise in late dioestrus 
to a maximum in proestrus. The rate remained high during 
oestrus , and then fell to its lowest level by the end of 
this phase. On the other hand, the progesterone secretion 
rate was low at the end of oestras, but rose in metoestrus 
until it reached a maximum in proestrus (Butcher, Collins & 
Fugo , 1974; Brenner & West, 1973)'
Both adrenergic and cholinergic autonomic neurones 
supply the rat uterus. Adham and Schenk (I969) demonstrated 
that cyclical changes occurred in the density of autonomic 
innervation during the oestrous cycle. Both adrenergic and 
cholinergic nerves were more numerous in oestrus than in 
dioestrus , while an intermediate number of these nerves were
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présent in proestrus and metoestrus. The adrenergic 
component of* the autonomic innervation in the rat uterus 
has been well characterized using histochemical, biochemical 
and morphological techniques (Silva^ I966; SjOberg, I967).
In an ultrastruetural study^ Silva (1966) showed that the 
density of uterine adrenergic innervation in the rat was 
low, when compared to other mammals. Silva (1966) found 
most of the nerve bundles to be associated with blood vessels 
although some were present in the myometrium. In both rats 
and humans , regional differences in the density of uterine 
adrenergic innervation have been shown by Owman, Rosengren 
and SjOberg (1967), and Adham and Schenk (1969)' In these 
species, there was an increasing density of adrenergic 
innervation from the ovarian to the cervical end of the 
uterus. However Norberg and Fredricsson (1966) found 
adrenergic nerves only in the region nearest to the tubo - 
uterine junction.
The blood vessels of the uterus are supplied by long 
adrenergic neurones, while the myométrial cells are innervated 
by short adrenergic neurones with ganglia located in or 
near the uterus.(SjOberg 1967)» The long and short 
adrenergic neurons have been shown to differ functionally 
in that with reserpine treatment, noradrenaline disappeared 
more slowly, but returned earlier in the latter than in 
the former (Owman & Sjüberg, I967). Changes in the nor­
adrenaline content of the short neurones have also been 
observed following oestrogen and progesterone treatment, 
and during pregnancy (Hervonen, Kanerva & Lietzen , 1973).
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Of* the species examined, the rat uterus has the lowest 
noradrenaline content^ which correlates well with the 
sparse adrenergic innervation (Silva, I966; Marshall, 1970). 
Sporrong, Clase, Owman and Sjôberg (l977) suggested that 
sensitivity of the short neurones to sex steroids may be 
the basis for the disappearance of noradrenaline selectively 
from these nerves during pregnancy. The ovarian hormones 
have been shown to affect not only the transmitter content 
of uterine adrenergic nerves, but also its turnover and 
overall neuronal activity (Marshall,I98I).
Variations in oestrogen and progesterone levels during 
the oestrous cycle can alter the uterine catecholamine 
content in neurones^ and possibly in extraneuronal sites. 
Rudzik and Miller (1962) were the first to show that uterine 
adrenaline stores were subject to periodic fluctuations 
in the four phases. Although the amount of adrenaline 
determined biochemically in oestrus was twice that obtained 
in dioestrus, no such changes in uterine noradrenaline was 
observed. Oestrogen treatment was also found to increase 
adrenaline , but not noradrenaline content in the rat uterus 
(Rudzik & Miller, 19^2; Spratto & Miller, I968 a,b).
Further studies by Falck, Gardmark^ Nybell^ Owman^ Rosengren 
and SjOberg (1974) revealed that neither ovariectomy nor 
oestrogen treatment altered noradrenaline content in the 
rat uterus. Ovarian hormonal influence on uterine adrenaline 
or noradrenaline content has also been demonstrated in 
humans (Dujovne, De Laborde, Carril^ Cheviakoff, Pedroza 
& Rosner , 1976).
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With, reference to the catecholamine content, the rat 
uterus can accumulate or bind catecholamines as shown with 
radiolabelled compounds injected systemically (Wurtman ,
Chu & Axelrod, I963; Green & Miller, 1966a). Wurtman et al.
(1963) found that during the oestrous cycle, uteri in
3
oestrus bound more H-adrenaline than those in dioestrus
while the binding of H-noradrenaline was actually decreased
3
in oestrus. Oestrogen treatment doubled H-adrenaline uptake 
in uteri from ovariectomized animals. Since phenylethanol- 
amine-N-methyl transferase was absent in the rat uterus 
Wurtman ^ Axelrod and Kopin (1963) suggested that the ^H- 
adrenaline must have been taken up from the circulation 
rather than synthesized in the uterus. To investigate this 
possibility  ^Green and Miller (1966b) measured plasma 
concentrations of adrenaline and noradrenaline, and found 
that the former increased while the latter decreased during 
oestins. Thus, cyclic variations in uterine adrenaline 
resulted from differences in the ratio of adrenaline to 
noradrenaline in the plasma, and in the altered ability 
of the uterus to bind these amines.
Marshall (l9?0) suggested that adrenaline binding and 
storage sites in the rat uterus may be different from those 
for noradrenaline on the basis of the following observations:
(a) adrenaline, but not noradrenaline was shown to be 
subjected to periodic fluctuations during the oestrous 
cycle and pregnancy (Wurtman , Chu & Axelrod, I963);
(b) imraunosympathectomy reduced noradrenaline, but not the
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adrenaline content (Klingman, I965)» (c) cocaine prevented
the uptake of noradrenaline, but not adrenaline (Spratto & 
Miller, 1968a). Presumably, noradrenaline is stored in 
the adrenergic neurones, but the adrenaline storage site is 
unknown. The myométrial cells may serve as one of the 
adrenaline storage sites (Marshall, 1970).
Despite the above evidence, the physiological significance 
of oestrogen effects on uterine catecholamine content or 
accumulation is yet to be determined. Indeed, Spaziani 
(1975) suggested that there was no convincing evidence that 
the rat uterus required catecholamines or even a nervous 
system for normal function on the basis of the following 
reports: (a) denervation of the uterus (resulting in
depletion of 80^ of its noradrenaline content) did not 
interfere with changes during the oestrous cycle, conception 
and pregnancy (Barnea & Shelesnyak, I965); (b) total 
depletion of uterine noradrenaline content with 6-hydroxy- 
dopamine did not interfere with the ability of oestrogen 
to increase uterine blood flow (Brody, Edvinsson & Sjëberg,
1975).
As well as changes in uterine catecholamine content, 
morphological changes have also been demonstrated in the 
myometrium during the oestrous cycle and pregnancy (Silva,
1966; Spratto & Miller, 1968a; Digges, I980). During the 
oestrous cycle , the myometrium is thinner in dioestrus 
than in oestxnis. Naftalin, Phear and Goldberg (l973)
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suggested that these morphological changes may underlie 
the variation in mechanical tension developed in uteri 
from different hormonal conditions. The increased tension 
developed by the rat uterus during pregnancy may be due 
to the formation of cell to cell contacts or gap junctions 
(Garfield, Kannan & Daniel, I980). These specialized types 
of contacts may serve to couple cells together and allow 
the synchronized muscle contractility of labour (Mackenzie, 
Puri and Garfield, 1983)»
In summary, both anatomical and physiological changes 
occur in the rat uterus as a consequence of the cyclical 
production of oestrogen and progesterone during the oestrous 
cycle and pregnancy. The mechanism responsible for these 
changes are however, not well understood.
B. RAT UTERINE ADRENOCEPTORS
Ahlquist (1948, I962) classified mammalian uterine 
adrenoceptors into a-excitatory and P-inhibitory receptors 
but only the latter type was deemed to be present in the 
rat. The classification of rat uterine adrenoceptors is, 
however controversial since evidence from literature reveals 
that there may be more than one adrenoceptor subtype in 
this tissue.
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1 • Evidence for the occurrence of P —adrenoceptors
In support of Ahlquist's (1962) classification of 
rat uterine adrenoceptors^ Levy and Tozzi (1962) showed 
that P-receptor antagonists^ dichloroisoprenaline and 
pronethalol blocked catecholamine inhibitory responses in 
this preparation. Using the radioligand binding technique, 
Krall, Mori, Tuck, Le Shon and Korenman (1978) and Digges 
(1980) confirmed the presence of P-adrenoceptors in the 
uterus throughout the oestrous cycle. Indeed P-inhibitory 
adrenoceptors are similar in both depolarized (Schild, I966 
1967; Marshall & Kroeger , 1973) and non-depolarized 
(Diamond & Brody, I966; Miller, I967; Chow & Marshall ,
I98I; Boyle & Digges , 1982a,b; Acritopoulou-Fourcroy,
Clabaut & Schrub , I985) rat uterus.
Lands, Ludena and Buzzo (1967) subclassified P- 
adrenoceptors into and P^ with the rat uterus possessing 
mainly the P^-subtype (Olsson & Persson, 1971; Levy & 
Apperley , 1978). However, Richardson and Nahorski (1978) 
using the radioligand binding method, demonstrated the 
presence of both P^- and P^-adrenoceptors in oestrogen 
treated, but not in progesterone treated rat uteri. In 
oestrogen dominated rat uterus, the ratio of P^-zP^- 
receptors was 20^^80^ while in progesterone dominated tissues, 
all the receptors are of the P^-type (Nahorski, 198I).
In summary, the occurrence of P-inhibitory adrenoceptors 
in the uterus from both non-pregnant and pregnant rats has 
been generally accepted.
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2• E)vidence for the occurrence of a-adrenoceptors
In 1949, Mann reported that both noradrenaline and 
adrenaline produced excitatory effects in uteri from the 
oestrus phase, and in those from ovariectomized rats treated 
with oestrogen. Similar catecholamine-induced stimulant 
action was demonstrated in the oestrogen dominated rat 
uterus by Brooks, Schaeppi and Pincus (1963) and by 
Diamond and Brody (1966). Tothill (1967) showed that 
in vi tro treatment of the rat uterus with isoprenaline 
reversed the inhibitory effects produced by catecholamines 
to a motor response. The motor response was blocked by 
a-adrenoceptor and 3-hydroxytiyptamine receptor antagonists. 
Tothill (1967) then proposed the existence of an excitatory 
receptor designated the "E—receptor" since both a- and 
5-hydroxytryptamine receptors appeared to be involved in 
the response. However, Paton (1968) failed to demonstrate 
the presence of the "E-receptors" but found that both the 
catecholamines and 3-hydroxytryptamine acted on separate 
excitatory receptors in the rat uterus.
The presence of distinct uterine a-excitatory receptors 
in animals during oestrus has since been confirmed by other 
workers (Butterworth & Randall, 1970» Abdel-Aziz & Bakry^ 
1973; Butterworth & Jarman , 1974; Boyle & Digges^ 1982a). 
The a-adrenoceptors appeared to be more temperature sensitive 
than the P-inhibitory receptors (Butterworth & Jarman,
1974). In the myometrium, the existence of a-excitatory
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receptors has been demonstrated in the circular^ but not 
in the longitudinal muscle layer^ in both non—pregnant 
and pregnant animals (Kawarabayashi & Osa, 1976; Chow & 
Marshall, I98I; Kishikawa , I981). In general , evidence 
in favour of the presence of a-excitatory receptors in 
the rat uterus is consistent, and these receptors may be 
associated with conditions of oestrogen dominance. However^ 
there are some reports that the a—adrenoceptor population 
in this tissue may subserve an inhibitory function.
Wiqvist (1939) found that both dihyroergotamine and 
phentolamine blocked adrenaline inhibitory action in the 
rat isolated uterus. Jensen and Vennerod (1961) also showed 
that tolazoline antagonized adrenaline inhibitory effects 
on 5-bydroxytryptamine-induced contraction in this tissue 
suggesting that the a-adrenoceptors subserved relaxation.
As a result of these reports, Rudzik and Miller (1962) 
investigated the occurrence of a-inhibitory adrenoceptors 
in the rat uterus. Adrenaline, noradrenaline and phenylephrine 
produced inhibitory effects which were antagonized by 
phentolamine. Although phenylephrine and isoprenaline are 
known to be specific for a- and P-adrenoceptors , respectively^ 
they both produced an inhibitory response. Thus , Rudzik 
and Miller (1962) suggested that both uterine a- and P- 
adrenoceptors may be involved in the catecholamine-induced 
inhibitory effects.
However, the concept of a-inhibitory adrenoceptors in 
the rat uterus is equivocal since other workers using the
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same adrenoceptor antagonists failed to demonstrate their 
blocking effects on catecholamine inhibitory responses. 
Indeed ^ some workers have reported an enhanced adrenaline 
iïiLibition after a—receptor blockade (Brooks et al. , 1965)* 
The antagonists used in the studies that favoured the 
presence of a-inhibitory adrenoceptors (Wiqvist, 1959»
Jensen & Vennerod, I96I; Rudzik & Miller, I962) have since 
been shown to produce non-specific excitatory effects on 
uterine smooth muscle (Tothill, I967; Paton, I968). This 
non-specific action may be responsible for the observed 
blockade of catecholamine inhibitory responses in the rat 
uterus•
In summary, it appears that rat uterine a-adrenoceptors 
subserved an excitatory rather than an inhibitory function. 
The presence of a-adrenoceptors in the uterus has been 
confirmed by Krall e_t (1978) using the radioligand
binding technique. The existence of a-adrenoceptors in the 
rat uterus does not conform with Ahlquist's (1962) classifi­
cation of adrenoceptors in this tissue. However , the 
above evidence strongly supports the view that the rat 
uterus possessed both a- and P-adrenoceptors, and is thus 
similar to uteri from other mammals.
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C' FACTORS INFLUENCING ADRENOCEPTOR AGONIST RESPONSES IN 
THE RAT UTERUS
A number of factors can alter adrenoceptor mediated 
responses in the uterus by actions involving receptors , 
membrane permeability to ions and intracellular processes. 
These factors are : (l) ovarian hormones^ (2) catecholamine
uptake processes, (3 ) cyclic nucleotides , (4) ions, and 
(5 ) prostaglandins.
1. OVARIAN HORMONES
The ability of the ovarian hormones^ oestrogen and 
progesterone to modify uterine responses to catecholamines 
has been demonstrated in some species including the cat 
(Tsai & Fleming , 1964) and rabbit (Willems & De Schaepdryver, 
1966). In rats. Diamond and Brody (1966) reported that 
ovarian hormones may alter uterine responses to catecholamines 
by an action on the adrenoceptors. They found that an 
oestrogen treated muscle was excited by the amines (an a- 
adrenoceptor effect), while a progesterone treated one was 
inhibited (a P-adrenoceptor effect). Thus, they suggested 
that the response of the rat uterus to catecholamines 
could depend on the balance between a- and P-adrenoceptor 
activities, which in turn was regulated by the ovarian 
hormones. Krall ^  (1978) confirmed these observations
using the radioligand binding method. They found that the 
rank order of affinity of the catecholamines for displacement
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of “dihydroalprenolol binding (isoprenaline >
adrenaline >  noradrenaline) in the four phases of the 
oestrous cycle was similar to that for inhibition of 
myométrial motility. During the oestrous cycle, myométrial 
a-adrenoceptor content was increased in proestrus and oestrus 
while P-adrenoceptor content was raised only in proestrus. 
Krall ejb a^. (1978) suggested therefore  ^that changing
receptor number might be one way through which the hormones 
regulated target organ function.
Oestrogen and progesterone may also produce direct 
effects on myométrial motility. In vitro treatment of the 
myometrium with the hormones has been shown to inhibit both 
its electrical and mechanical activity in humans (Mossman & 
Conrad, I967) and rats (Saldivar & Melton, I966; Pharriss 
& Russell, 1968). The mechanism of this inhibitory effect 
is unclear, and its implication for the response of the 
rat u t e m s  to catecholamines remains to be determined.
2. CATECHOLAMINE UPTAKE PROCESSES
The existence of mechanisms whereby the neurotransmitter, 
noradrenaline can be taken up both into neuronal (Uptake^) 
and extraneuronal (Uptake^) sites is well known (as reviewed 
by Gillespie, 1973 and Iversen, 1973)« These processes are 
physiologically important in terminating the actions of 
noradrenaline at the synaptic gap, but have pharmacological 
relevance in explaining the mechanism of action of some 
adrenergic drugs (O'Donnell & Wanstall , 1976; Kenakin, 1983)»
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Indeed, differences in the uptake of adrenoceptor agonists 
may account for some of the observed variation in agonists 
potencies (Kenakin , 1984).
Various steroids including oestradiol-17P and 
progesterone, have been shown to be potent inhibitors of 
the Uptake^ process (iversen & Salt, 1970; Salt, 1972).
Thus, Bell (1972) suggested that both the changes in uterine 
neuronal stores of noradrenaline and the apparent capacity 
to accumulate adrenaline in extraneuronal stores could 
depend on the oestrogen and progesterone balance during 
the oestrous cycle. In I982 , Boyle and Digges showed that 
the variations in the ovarian hormones in proestrus, oestrus, 
metoestrus and dioestrus were accompanied by variations in 
uterine uptake of the catecholamines. They also found 
that blocking Uptake^ alone produced effects similar to 
blocking both Uptake^ and Uptake^ processes which would 
suggest that in the rat uterus, the Uptake^ process was 
the more important. The physiological significance of 
the effects of oestrogen and progesterone on the Uptake^ 
process is, however not clear, and merits further investigation,
3. CYCLIC NUCLEOTIDES
(a) Adenosine 3'»5* cyclic monophosphate metabolism
An increase in tissue levels of adenosine 3', 5' cyclic 
monophosphate (cAMP) is a prominent feature of the effect of 
P-adrenoceptor activation in the rat uterus, as in other
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organs. However, controversy exists concerning the precise 
mechanism whereby the rise in tissue cAMP produces the
tory response. The evidence available supports the 
view that cAMP is a mediator of rat uterine response to 
catecholamines. There is a parallel dose-response relation­
ship between the concentration of the catecholamines required 
to produce relaxation and to increase tissue cAMP content 
(Dobbs & Robison, I968; Triner, Nahas, Vulliemoz, Overweg, 
Verosky, Habif & Ngai , 1971)* Robison (l970) showed that 
the ability of various catecholamines to relax the uterus 
and to increase its cAMP content was directly related to 
their potency at the P-adrenoceptor site. Both the relaxation 
and the increase in tissue cAMP content were prevented by 
P-adrenoceptor antagonists (Mitznegg , Heim & Meythaler, 1970; 
Bhalla , Sandbom & Korenman, 1972), and potentiated by 
inhibitors of phosphodiesterase (Triner ejb aT., 1971 ) * The
increase in tissue cAMP content produced by stimulation of 
P-adrenoceptors also correlated temporally with relaxation 
(Marshall & Kroeger, 1973; Johansson & Andersson, 1978).
The dibutyryl derivative of cAMP has been shown to mimick 
the relaxant effect of the catecholamines (Mitznegg ejt aJ. , 
I97O; Triner ^  aT., 1971; Vesin & Harbon, 1974). Further 
studies have also confirmed the involvement of cAMP in 
the inhibition produced by the catecholamines (Krall & 
Korenman ^ 1979; Kroeger, 1979; Kishikawa, I98I). In the 
myometriumj the longitudinal muscle has been demonstrated 
to possess a higher level of adenylate cyclase than the
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circular muscle ^ which may account for the greater 
sensitivity of the former layer to P—adrenoceptor activation 
(Fortier & Krall, 1983). Thus , many of the criteria for 
establishing cAMP as a "second messenger" for the effects 
of P-adrenoceptor stimulation have been satisfied in the 
rat uterus.
There is evidence, however, against the involvement of 
cAMP as a mediator of rat uterine response to the catecholamines. 
Both nitroglycerine (which has no effect on tissue cAMP 
content) and theophylline (an inhibitor of phosphodiesterase) 
potentiate the relaxant effect of the catecholamines (Levy 
& Wilkenfeld, I968). Polacek and his co-workers (Polacek,
BoIan & Daniel, 1971; Polacek & Daniel , 1971) could not 
demonstrate a temporal correlation between the increased 
tissue cAMP content produced by the catecholamines and 
relaxation. Harbon and Clauser (1971) found that the 
relaxant, adrenaline and the stimulant, prostaglandin 
both increased tissue cAMP content. Later workers have 
also reported a discrepancy between tissue cAMP content 
and the relaxation produced by catecholamines (Diamond &
Holmes, 1975» Meisheri & McNeill, 1979a,b; Marshall &
Fain, 1985)»
The above evidence shows that under certain conditions ^ 
while cAMP can mediate relaxations in the rat uterus, the 
nucleotide may not be an obligatory mediator. It thus 
appears that P—adrenoceptor activation can affect muscle 
tension via cAMP-independent, as well as cAMP-dependent 
mechanisms.
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Acute administration of* the ovarian hormone , oestrogen 
has been shown to elevate cAMP levels in the rat uterus, an 
effect prevented by P—adrenoceptor antagonists (Szego & 
Davies, I969; Sandborn, Bhalla & Korenman, 1973)« It 
appears that cAMP may play an intermediary role in the 
action of oestrogens in the rat uterus (Marshall, 1973» 
Downing & Porter, I98O; Kishikawa^ I98I). The precise 
mechanism whereby oestrogen increases uterine cAMP level 
is, however, not well understood.
(b) Guano sine 3*. 5* cyclic monophosphate metabolism
Guanosine 3',5' cyclic monophosphate (cGMP) and cAMP 
have been proposed to function in a reciprocal fashion in 
the control of smooth muscle motility (Lee , Kuo & Greengard, 
1972; Schultz, Hardman, Schultz, Davis & Sutherland, 1973) 
The localization of cGMP and its protein kinase in the 
plasma membrane and cytoplasm of rat uterine cells has 
been demonstrated by Flandroy, Cheung and Steiner (1983). 
Although ovarian hormones have been shown to affect cGMP 
levels in the rat uterus, the physiological significance of 
this action remains obscure (Flandroy & Galand, 1978, I98O; 
Kishikawa, I98I ). However, no temporal association has 
been found between cGMP levels and rat uterine motility 
(Diamond & Hartle, 1974; Diamond & Holmes, 1975; Leiber, 
Vesin & Harbon, 1978; Janis & Diamond, 1979)«
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4. IONS
The ionic mechanisms responsible for catecholamine 
tory responses have been studied by observing changes 
in electrophysiological properties of uteri exposed to 
different ionic media. As early as 1959 , Goto and Csapo 
showed that the ovarian hormones, oestrogen and progesterone 
altered calcium movements in the rat isolated uterus.
They found that in a calcium-free medium, uteri under 
oestrogen influence quickly depolarized and lost all 
excitability within 20 minutes , while those under progesterone 
influence required 90 minutes to depolarize to the same 
extent. Thus , it would appear that calcium ions in the 
superficial (membrane) sites may be more firmly bound under 
progesterone influence (Goto & Csapo, 1959; Marshall, I962).
Csapo and Kuriyama (1963) and Marshall (1968) showed 
that the hyperpolarization produced by catecholamines in 
the rat uterus was related to the potassium ion concentration 
in the extracellular fluid. They observed that in a 
potassium-free medium, the amine-induced hyperpolarization 
was increased while in an external potassium concentration 
of greater than 30 mM , the amine-induced hyperpolarizatibn 
decreased. On the other hand, changes in extracellular 
sodium or chloride ion concentrations did not affect 
hyperpolarization. Thus, Marshall (1968 , 1970) suggested 
that the inhibitory effect of catecholamine may be due to 
a specific increase in potassium permeability. In 1973 
Marshall and Kroeger found that the amine-induced hyper-
—  3 6 —
polarization was dependent on the calcium concentration 
in the external medium. Ouabain and low temperature (lO^C) 
reduced the hyper polari zat ion by 30^ , indicating that some 
metabolic process was involved. Marshall and Kroeger (l973) 
therefore proposed that hyperpolarization may involve an 
electrogenic calcium pump activated by cAMP. Indeed, an 
outwardly directed calcium current could underlie the 
relaxation produced by catecholamines in the rat uterus 
(Kroeger, Marshall & Blanchi, 1975; Marshall, 1977).
Adrenoceptors may also play a role in the regulation 
of ion permeability of myométrial cells, and in this manner 
control uterine response to the catecholamines. Diamond and 
Marshall (l9^9a,b) showed that membrane potential changes 
accompanying the stimulatory or inhibitory effects of the 
catecholamines were reversed in the presence of the 
appropriate a- or 1^ -adrenoceptor antagonist. Based on the 
assumption that eil terations in the ionic permeability of 
the membrane underlie the membrane potential changes,
Marshall (l970 ,1973) suggested that effects on both a-
and -adrenoceptors could be mediated through these permeability
changes.
The involvement of ions in the excitatory action of 
catecholamines was studied in the guinea-pig uterus by 
Bulbring and her co-workers who showed that depolarization 
may be due to an increase in chloride ion permeability 
(Szurszewski & Bulbring, 1973; Bulbring & Szurszewski, 1974; 
Bulbring Ohashi & Tomita, 1981). Lanthanum ions had no
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on depolarization or membrane resistance, but 
abolished the tension response suggesting that an influx 
of calcium ions may be necessary to maintain tension.
Cooling to 6 0 abolished the excitatory effect of cate­
cholamines on both membrane potential and tension. Thus, 
some intermediary metabolic process may precede the increase 
in chloride permeability that caused depolarization (Bulbring 
et al. 1981).
The above evidence highlights the importance of ions 
in the response of the rat uterus to catecholamines. It 
appears that calcium ions play a pivotal role in both the 
stimulatory and inhibitory effects of the catecholamines 
in this organ.
5 . PROSTAGLANDINS
The biological importance of prostaglandins in mammalian 
reproduction is well known (as reviewed by Goldberg &
Ramwell, 1975 and Horton & Poyser, I976). The role of 
prostaglandins in the regulation of rat uterine motility 
can be discussed on the basis of their production throughout 
the oestrous cycle, and the possible interactions between 
them and the cat echolamines.
In their classic study. Vane and Williams (l973) showed 
that both indomethacin and meclofenamate antagonized the 
stimulant effects of oxytocin in the non-pregnant rat uterus, 
while contractions induced by acetylcholine and prostaglandin 
were unaffected. Uteri from rats in late pregnancy
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spontaneous activity and released prostaglandins 
into the bathing medium. Both the prostaglandin release 
and uterine activity were abolished by indomethacin. Vane 
and Williams (1973) suggested, therefore, that rat uterine 
spontaneous activity may be due to intramural prostaglandin 
generation, and that increased prostaglandin production 
contributes to the expulsion of the foetus during parturition. 
Similar observations have been made by other workers (Harney, 
Sneddon & Williams , 1974; Dubin, Ghodgaonkar & King, 1979; 
Gimeno, Sterin-Speziale , Landa, Bonacossa & Gimeno, 1979)*
Franchi, Chaud, Borda, Gimeno, Lazzari and Gimeno (198I) 
measured prostaglandins in the bathing medium, and found 
that uteri from rats in pro es tins and oestrus released more 
prostaglandin F, while those from metoestrus and dioestrus 
released more prostaglandin E. However, uterine homogenates 
have been shown to produce more prostaglandins E and F in 
proestrus and oestrus, than in metoestrus and dioestrus 
(Van Orden , Goodale , Baker, Barley & Bhatnagar, I98O;
Poyser & Scott, I98O; Brown & Poyser, I985). In order to 
explain the discrepancy in results. Franchi et (198I)
and Gimeno and Gimeno (1984) suggested that the intrinsic 
capacity of the rat uterus to synthesize prostaglandins E 
and F may depend on the integrity of the tissue. Although 
both the myometrium and endometrium can synthesize 
prostaglandins, the endometrium has been shown to be the 
major source of uterine prostaglandins in the rat (Campos , 
Liggins & Seamark, I98O; Brown & Poyser, 1985)*
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Oestrogen and progesterone have been reported to
regulate rat uterine prostaglandin biosynthesis and release 
(Castracane & Jordan, 1975? Carminati, Luzzani, Soffientini 
& L e m e r  , 1975» Kogo, Yamada & Ai z aw a , 1977 5 Sterin-Speziale, 
Gimeno, Bonacossa & Gimeno, I980). Although oestrogen was 
regarded as the predominant ovarian steroid involved in the 
regulation of prostaglandin biosynthesis, a prior period of 
exposure to progesterone may be necessary (Castracane &
Jordan, 1976; Gimeno & Gimeno, 1984). Conflicting results 
however, exist as to which of the prostaglandins (E or F 
series) was most affected by the hormones. Oestrogen 
treatment has been shown by some workers to increase uterine 
prostaglandin F synthesis alone (Ham, Cirillo , Zanetti &
Kuehl, 1975; Sterin-Speziale e_6 aJ. , 1980)^ while other 
workers found that both uterine prostaglandins E and F 
syntheses were augmented (Sharma & Garg, 1977; Wilson, 1983)*
Both prostaglandins E and F can produce excitatory 
effects on uterine motility. The evidence available suggests 
that prostaglandins may stimulate uterine contraction by 
a direct effect on intracellular binding sites for calcium 
leading to a decrease in calcium storage (Carsten, 1974;
Reiner & Marshall, 1976; Carsten & Miller, 1977). In I966, 
Clegg reported that very low concentrations of prostaglandins 
antagonized cat echolamine—induced inhibitory responses in 
the rat uterus. Since then, similar interactions between 
prostaglandins and catecholamines have been demonstrated by 
Vesin and Harbon (1974), and by Krall, Barrett , Jamgotchian
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& Korenman (1984).
Biochemical studies have shown that catecholamines 
can stimulate prostaglandin biosynthesis and release from 
various tissues including the kidney (Davis & Horton, 1972), 
heart (Wennmalm & Brundin, 1978; Weis & Malik, I985), 
seminal vesicles (Egan, Humes & Kuehl, 1978) , cultured cells 
(Levine & Moskowitz , 1979) and spleen (Bedwani & Millar,
1975; Bruckner-Schmidt , Jackish & Hertting, I98I). A 
direct effect of the catecholamines on cyclo-oxygenase may 
be responsible for the increased prostaglandin production 
(Egan ejt ad. 1978; Baumann, v. Bruchhausen & Wurm, 1979)»
As well as prostaglandins, non-pregnant and pregnant 
uteri have been shown to produce other metabolites of 
arachidonic acid which include the leukotrienes (Carraher, 
Hahn, Ritchie & McGuire, I983) and prostacyclins (Williams, 
Dembinska-Kiec , Zmuda & Gryglewski , 1978; Vesin, Do Khac 
& Harbon , 1979; Franchi et al. I98I; Brown & Poyser , I985). 
However^ the involvement of leukotrienes (Carraher et al.
1983) and prostacyclins (Gimeno & Gimeno, 1984) in the 
regulation of rat uterine motility is less clear.
The above evidence shows that several factors including 
types of adrenoceptors, ovarian hormones, agonist uptake 
processes, cyclic nucleotides, ions and prostaglandins can 
modulate rat uterine response to the catecholamines. These 
factors affect events not only at the adrenoceptor sites 
but also, those relating to catecholamine-induced changes 
in cellular function as a whole.
- 4l -
Despite the fact that adrenoceptor mediated inhibition 
in the rat uterus has been extensively studied, controversy 
still exists as to the mechanisms that underlie the altered 
uterine responses during the oestrous cycle. The conflicting 
results in literature may be due to the lack of standardization 
of the experimental procedure employed. For instance, some 
workers induced a particular phase of the oestrous cycle 
by pretreating animals with various doses of oestrogen and 
progesterone (Levy & Tozzi, I963; Diamond & Brody, I966; 
Tothill, 1967; Paton, I968; Harbon & Clauser, 1971;
Bengtsson , 1978; Meisheri & McNeill, 1979a b; Kishikawa, 
1981), while others did not identify the hormonal state of 
the animals used in their studies (Ahlquist, 1948; Brooks, 
et al . 1963; Paterson, I963; Schild, I967 ; Lands ejb al.. 
1967; Vane & Williams, 1973)» Indeed, only a few workers 
used uteri from rats in the naturally occurring phases of 
the oestrous cycle (Butterworth & Randall, 1970; Abdel-Aziz, 
and Bakry , 1974; Butterworth & Jarman, 1974; Krall ^  al.. 
1978; Boyle & Digges, 1982a).
The aim of the present study was therefore, to 
investigate the mechanism responsible for the variation in 
uterine response to the catecholamines throughout the natural 
oestrous cycle by examining: (a) rat uterine response to
adrenoceptor agonists in each of the four phases in order 
to establish control conditions, (b) the contribution of 
a-receptor activity, agonist uptake processes and ovarian 
hormones to the overall response, and (c) the possible role
-  42 -
of intramural prostaglandin generation, adenosine 3 5  ' 
cyclic monophosphate metabolism and calcium function in 
the altered uterine response during the oestrous cycle.
METHODS
- 43 -
A. ANIMALS
Virgin female Wistar rats were used in all experiments. 
For experiments on the oestrous cycle, animals weighing 
180 g to 230 g were used. Ovariectomized rats were purchased 
from Charles River U.K. Limited. The animals weighed
(200-260 g), and were used l4 or more days after bilateral
ovariectomy.
B. VAGINAL SMEARS
In rats, cyclical production of ovarian hormones results 
in an oestrous cycle which lasts 4 to 3 days, and can be
divided into four phases - proestrus, oestrus, metoestrus and
dioestrus. While the primary events take place in the ovaries 
and uterus, changes also occur in the vagina which undergoes 
cyclical disintegration. The debris accumulates in the 
lumen and can be used to identify the four phases of the 
cycle. The events occurring in the ovaries, and the vaginal 
histology of rats in proestrus, oestrus, metoestrus and 
dioestrus are summarized in Table 1.
Vaginal smears were taken immediately after the animal 
was killed. 0.3 ml of distilled water was inserted into the 
vagina from a pasteur pipette. The fluid containing shed 
vaginal cells was then withdrawn, placed on a glass slide, 
and air dried. The smears were stained with 0.1% methylene 
blue and examined under a microscope. Vaginal smears from 
each phase of the oestrous cycle are shown in Plate 1.
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Plate 1: Vaginal smears
A. Proestrus
B. Oestrus
C. Metoestrus
D. Dioestrus
nucleated epithelial cells only, 
cornified squamous cells only, 
cornified cells, nucleated 
epithelial cells and polymorpho- 
nucleated leucocytes, 
nucleated epithelial cells and 
leucocytes.
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C. ISOLATED UTERINE HORN PREPARATIONS
Animals were killed by stunning and exsanguination.
In both intact and ovariectomized rats, 2-3 cm lengths 
from the mid-portion of each uterine horn were used. The 
tissues were mounted in paired 10 ml organ baths containing 
Tyrode solution (see Table 2) at 37°C, and gassed with a 
95% 02:5% COg mixture. Isometric tension was recorded via 
Grass FTO3 force displacement transducers, and displayed on 
a Grass Model 7D polygraph. An initial tension of 0.5 g 
was applied to each horn, and the tissues were left to 
equilibrate for at least 1 hour. Uteri from animals in the 
metoestrus and dioestrus phases usually exhibited spontaneous 
activity on mounting. However, the spontaneous activity 
disappeared after exposure of the tissues to acetylcholine 
or potassium chloride.
1. EXPERIMENTS IN UTERI FROM INTACT ANIMALS
(a) Responses to motor agents
Since the rat uterus does not possess intrinsic tone, 
it was necessary to induce tone in order to display the 
relaxation produced by drugs. Various methods have been 
used; 5-hydroxytryptamine (jensen & Vennerod, I961); 
potassium chloride (Marshall & Kroeger, 1973); acetylcholine 
(Boyle & Digges, 1982a)and field stimulation (Clegg, 1966).
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In the present study, acetylcholine and potassium chloride 
were used to induce tone in uteri from the four phases of 
the oestrous cycle, and after ovariectomy.
(i ) Acetylcholine
Dose-response curves were constructed to acetylcholine 
(ACh) in each preparation. Doses of ACh were added every four 
minutes, and allowed to act for 30 seconds, before being 
washed out. The dose that produced approximately 60-70% 
of the maximum response to ACh was chosen as a standard 
which was used throughout the remainder of the experiment.
The response to the standard dose of ACh at the end of 
each experiment was not significantly different from that 
at the start of the experiment.
(ii) Potassium chloride
Preliminary experiments showed that the optimum 
concentration of potassium chloride (KCI) for inducing tone 
in the four phases of the oestrous cycle was 5 x 10 ^M.
This concentration of KCI produced a biphasic contractile 
response with an initial transient phase, followed by a 
secondary sustained phase. The secondary sustained phase 
lasted for more than 1 hour, enabling cumulative dose-response 
curves to be constructed to the relaxant drugs.
(b) Adrenoceptor agonists inhibitory responses
The inhibitory responses to the adrenoceptor agonists, 
noradrenaline (NA), adrenaline (ADR) and salbutamol (SAL),
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were examined in uteri in which tone was induced with either 
ACh or KCI. In each experiment, only one adrenoceptor 
agonist was used.
When tone was induced with ACh, the adrenoceptor 
agonists were added to the organ bath 30 seconds before 
the standard dose of ACh. The inhibitory effect of the 
adrenoceptor agonists was determined as percentage reduction 
of ACh motor response. After inhibition with the agonists, 
the standard ACh response was allowed to recover fully 
before addition of the next dose of agonist.
When KCI was used to induce tone, cumulative dose- 
response curves to the adrenoceptor agonists were constructed 
15 minutes into the sustained phase, until maximum relaxation 
of the induced tone was achieved. The adrenoceptor agonist 
dose was added using a 2 minute cycle. The inhibitory 
responses to the agonists were expressed as percentage 
relaxation of KCl-induced tone.
In all subsequent experiments, control responses to 
ACh or KCI and the adrenoceptor agonist under investigation 
were obtained, before the addition of any antagonists. 
Experiments in the presence of the adrenoceptor agonists 
alone are referred to as the Control I studies.
(c) Adrenoceptor agonists inhibitory response in the presence 
of an a-receptor antagonist
The existence in the uterus of a-excitatory receptors 
in addition to the well characterized i^-inhibitory receptors.
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could influence the response to adrenoceptor agonists active 
at both receptors. The observed response to such agonist 
would then be the algebraic sum of contraction plus relaxation. 
In a series of experiments, a-receptor activity was abolished 
by using azapetine (AZA). AZA (10”^M) was added to the 
Tyrode solution, and was present throughout the remainder 
of the experiment. Tissues were exposed to AZA for at 
least 30 minutes before addition of the adrenoceptor agonists.
(d) Adrenoceptor agonists inhibitory responses in the 
presence of inhibitors of neuronal and extraneuronal uptake
Agonist concentration at the receptor could be affected 
by amine removal mechanisms, i.e. uptake into neuronal 
(Uptake ^ ) and non-neuronal (Uptake ^) tissues. The 
contribution of the uptake processes to adrenoceptor agonists 
inhibitory responses was studied by using desmethylimipramine 
(DMI) to block Uptake^ and normetanephrine (NMN) to block 
Uptake^. When used, both DMI (lO ^M) and NMN (lO ^M) were 
present in the Tyrode solution throughout the remainder of 
the experiment. Tissues were exposed to DMI and NMN for 
at least 30 minutes before addition of the adrenoceptor 
agonists.
(e ) Adrenoceptor agonists inhibitory responses in the 
presence of an a-receptor antagonist and inhibitors 
of neuronal and extraneuronal uptake
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Since both a-excitatory receptors and amine removal 
mechanisms affected adrenoceptor agonist responses, a series 
of experiments was performed in which AZA (10”^M), DMI 
(10 M) and NMN (lO ^M) were present in the Tyrode solution. 
Such experiments are referred to as Control II studies.
(f ) Adrenoceptor agonists inhibitory responses in the 
presence of a cyclo-oxygenase inhibitor
Intramurally generated prostaglandins produce excitatory 
effects on uterine motility. The possibility that prosta­
glandins may influence the inhibitory responses of adrenoceptor 
agonists was investigated in two series of experiments in 
which their biosynthesis was prevented by inhibiting cyclo- 
oxygenase with flurbiprofen (FBF). In the first series, 
the controls were of the Control I type i.e. agonists alone 
(See Section C.l(b)), while in the second series, controls 
were of the Control II type i.e. all three antagonists were 
present (See Section C.l(e)). FBF (10 ^M) was present in 
the Tyrode solution for the duration of these experiments. 
Tissues were exposed to FBF for at least 1 hour before 
addition of the adrenoceptor agonists.
(g) Adrenoceptor agonists inhibitory responses in the 
presence of an inhibitor of both cyclo-oxygenase 
and lipoxygenase
The prostaglandin precursor, arachidonic acid, is a 
substrate for lipoxygenase as well as for cyclo-oxygenase.
- 52 -
Thus inhibition of cyclo-oxygenase alone, may lead to 
augmented formation of leukotrienes from arachidonic acid.
The leukotrienes, may also influence adrenoceptor agonists 
inhibitory responses in the rat uterus. A series of 
experiments was therefore performed in the presence of 
B¥ 753c (3-amino-l-(m-trifluoromethyl)-phenyl-2-pyrazolone), 
an inhibitor of both cyclo-oxygenase and lipoxygenase. The 
controls in these experiments were of the Control II type.
BW 753 C (10 ^M) was present in the Tyrode solution through­
out the experiment. Tissues were exposed to BW 733C for 
at least 1 hour before addition of the adrenoceptor agonists.
(h) Histamine inhibitory responses
In the rat uterus, the inhibitory response to histamine
is due to activation of H^-receptors. In a series of
experiments, the effects of histamine were examined in uteri
—8in which tone was induced with ACh. Mepyramine (5 x 10 M) 
was added to the Tyrode solution to block H^-excitatory 
receptor activity. Histamine was added to the organ bath 
2 minutes before the standard dose of ACh. The inhibitory 
effect produced by histamine was measured as the percentage 
reduction of ACh motor response, which was allowed to 
recover fully before addition of subsequent doses of 
histamine.
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(i ) Histamine inhibitory responses in the presence of a 
cyclo-oxygenase inhibitor
The excitatory effect of prostaglandins on uterine 
motility could also influence histamine inhibitory responses 
in the rat uterus. This possibility was investigated in a 
series of experiments in which prostaglandin biosynthesis 
was blocked with the cyclo-oxygenase inhibitor FBF. FBF 
(lO ^M) was present in the Tyrode solution throughout the 
experiments. Tissues were exposed to FBF for at least 1 
hour before addition of histamine.
(j) Papaverine inhibitory responses
Uterine responses to the non-specific smooth muscle 
relaxant papaverine were examined in uteri in which tone 
was induced with ACh. Papaverine was added to the organ 
bath 1 minute before the standard dose of ACh. The inhibitory 
effect produced by papaverine was measured as the percentage 
reduction of the ACh motor response, which was allowed to 
recover fully before addition of the next dose of papaverine.
(k) Papaverine inhibitory responses in the presence of a 
cyclo-oxygenase inhibitor
Involvement of prostaglandins in the inhibitory responses 
to papaverine was investigated in a series of experiments 
in which their biosynthesis was inhibited with FBF. As 
described above, FBF (10”^M) was present in the Tyrode 
solution throughout the experiment. Tissues were exposed to 
FBF for at least 1 hour before addition of papaverine.
—  5^ “
2. EXPERIMENTS IN UTERI FROM OVARIECTOMIZED ANIMALS
(a) Adrenoceptor agonists inhibitory responses
The inhibitory responses to the adrenoceptor agonists 
NA, ADR and SAL were studied in uteri in which tone was 
induced with ACh, as in those from intact animals. Experiments 
in the presence of the adrenoceptor agonists alone are again 
referred to as Control I studies.
(b) Adrenoceptor agonists inhibitory responses in the 
presence of an a-receptor antagonist
The presence of functional a-receptors in uterus from 
ovariectomized rats was investigated in a series of experiments 
in which a-receptor antagonist, AZA was used. As with 
experiments in intact animals, AZA (lO ^M) was present in 
the Tyrode solution throughout the experiment.
(c) Adrenoceptor agonists inhibitory responses in the 
presence of inhibitors of neuronal and extraneuronal 
uptake
The effect of amine removal mechanisms on adrenoceptor 
agonists inhibitory response was also studied in uteri from 
ovariectomized rats. In these experiments, both Uptake^ 
and Uptake^ processes were blocked by DMI and NMN, respectively. 
DMI (10“^M) and NMN (10"^M) were both present in the Tyrode 
solution throughout the experiment.
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(d) Adrenoceptor agonist inhibitory responses in the presence 
of an a-receptor antagonist and inhibitors of neuronal 
and extraneuronal uptake
As in experiments in uteri from intact rats, a series 
of Control II experiments was performed in the presence of 
all three antagonists, AZA (lO ^M), DMI (lO ^M) and NMN 
(10“^M).
(e ) Adrenoceptor agonists inhibitory responses in the 
presence of a cyclo-oxygenase inhibitor
The possibility that intramural prostaglandin production 
may influence adrenoceptor against inhibitory responses in 
uteri from ovariectomized rats was investigated in experiments 
in which FBF (10”^M) was present in the Tyrode solution.
As in the study with intact rats. Control I and Control II 
series of experiments were carried out.
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D. MEASUREMENT OF ADENOSINE 3*5' CYCLIC MONOPHOSPHATE 
CONTENT IN THE UTERUS
Stimulation of P-adrenoceptors in the rat uterus 
increases tissue adenosine 3'5* cyclic monophosphate (cAMP) 
content. The effect of the P-receptor agonist, SAL on cAMP 
levels, was investigated in the four phases of the oestrous 
cycle.
(a) Extraction of tissue cAMP
Animals were killed, and the phase of the oestrous 
cycle identified from vaginal smears. The uterus was 
isolated, and 1 cm lengths of each horn were blotted and 
weighed. Tissues were incubated in Tyrode solution containing 
a phosphodiesterase inhibitor, theophylline (lO ^M), at 37°C 
for 1 hour. After incubation, the tissues were blotted dry 
and quickly transferred to small tubes containing 1 ml of
ice-cold 59^  trichloroacetic acid (T.C.A. ), which were left
in a cold room (2-4°C) for 2k hours.
0.5 ml of the T.C.A. extract was transferred from each
sample tube to a correspondingly marked tube, and 2 ml of
water saturated diethyl ether were added and vortexed for 
5 seconds. The ether phase was removed using a pasteur 
pipette and discarded. The process of adding ether, vortexing 
and removing the ether layer was repeated twice. Any 
remaining ether was evaporated off in a water bath at 80°C.
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Some crystals of calcium carbonate were added to each tube 
to neutralize any remaining T.C.A. and to maintain a 
constant sample pH.
(b) Assay of cAMP
The cAMP assay was performed using a radioimmunoassay 
kit purchased from Amersham International PLC. The assay 
is based on competition between unlabelled cAMP and a fixed 
quantity of tritium labelled compound for binding to a 
protein which has a high affinity and specificity for cAMP. 
Measurement of protein-bound radioactivity enables the 
amount of unlabelled cAMP in the sample to be calculated.
The amount of labelled protein - cAMP complex formed is 
related inversely to the amount of unlabelled cAMP present 
in the assay sample.
Separation of the protein bound cAMP from unbound 
nucleotide is achieved by adsorption of the free nucleotide 
on to coated charcoal, followed by centrifugation. An 
aliquot of the supernatant containing the bound nucleotide 
is then removed for liquid scintillation counting. The 
concentration of unlabelled cAMP is then determined from 
a linear standard curve.
(i ) Preparation of standard cAMP solution
0.5 ml Tris EDTA buffer (50 mM Tris/HCl solution 
containing k mM EDTA at pH 7-5) was added to each of four 
small glass tubes. 0.5 ml of adenosine 3*5* cyclic phosphate
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standard (320 pmol) was added to the first tube and mixed.
0.5 ml of this dilution was transferred to the second tube 
and mixed again. This procedure was repeated successively 
with each remaining tube. Together with the original solution, 
five concentrations of standard cAMP were prepared. 50 |il 
from each solution gave I6, 8, 4, 2 and 1 pmol and were used 
for preparation of the calibration curve.
(ii) Assay procedure
(1 ) l4 assay tubes for standards, and additional tubes for 
unknowns in duplicate, were maintained at 0°C in an ice bath. 
The tubes were labelled consecutively.
(2) 150 i^l of Tris EDTA buffer were pipetted into tubes 1 
and 2, which were used for the determination of blank counts 
per minute.
(3 ) 50 p.1 of Tris EDTA buffer were pipetted into tubes 3 and 
4 for determination of binding in the absence of unlabelled 
cAMP.
(4) Beginning with the lowest concentration of standard cAMP,
50 p.1 of each dilution were added into each successive pair 
of assay tubes (5-14).
(5) 50 p,l of each unknown sample, in duplicate, were added 
into the remaining assay tubes as required.
(6) 50 ^1 of the labelled compound adenosine 3'5* 
cyclic phosphate (5^Ci) were added to each assay tube.
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(y ) 100 ]il of the binding protein, purified from bovine 
muscle, were added to all tubes with the exception of the 
blanks.
(8) All tubes were vor*texed for 5 seconds.
(9 ) The tubes, contained in the ice bath, were left in the 
cold room (2-4°C) for 2 hours.
(10) Fifteen minutes before the end of incubation time,
20 ml of ice-cold distilled water were added to the charcoal 
reagent in a beaker, which was placed in an ice bath and 
stirred continuously with a magnetic stirrer.
(11) 100 p,l of the charcoal suspension were added to all 
assay tubes and vortexed for 5 seconds. Charcoal was added 
only to the number of tubes which could be centrifuged in 
one batch.
(12) The tubes were centrifuged at 12,000g for 5 minutes 
in a refrigerated centrifuge to sediment the charcoal.
(13) Without disturbing the sediment, a 200 p.1 sample from 
each tube were removed and placed in vials containing 10 ml 
of scintillant ES 299»
(14) Samples were counted for radioactivity in a Packard 
Tri-Carb liquid scintillation spectrometer (Model 3390).
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(iii) Preparation of standard curve for cAMP assay
(1) The blank counts per minute (c.p.m.) for the assay 
were determined from the mean c.p.m. for tubes 1 and 2.
(2) The c.p.m. bound in the absence of unlabelled cAMP 
(C^) were obtained from the mean c.p.m. for tubes 3 and 4, 
and then subtracted from the blank c.p.m.
(3 ) The c.p.m. bound in the presence of unlabelled cAMP 
(C^) were determined by first averaging the c.p.m. for each 
pair of duplicates in tubes 5-14 for the standard, and the 
additional pairs of tubes for the unknowns. The results 
were then subtracted from the blank c.p.m. to give C .
(4) C /C was calculated for each concentration of standard ' ' o' X
cAMP and the unknowns.
(5) C^/C^ was plotted against pmoles of standard cAMP/tube 
to give the standard curve as shown in Figure 1. A straight 
line was obtained with an intercept of 1.0 on the ordinate.
(6) From the C /C value for the unknowns, the number of ' o x '
pmoles of cAMP was read from the standard curve. The cAMP 
concentration was expressed as pmol/g wet weight of tissue.
(c) Measurement of basal tissue levels of cAMP in the four 
phases of the oestrous cycle
Since variation in the ovarian hormones may affect cAMP 
generation, basal cAMP levels were measured in uteri from
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(f) Effect of a P-adrenoceptor agonist on cAMP levels in 
the presence of a cyclo-oxygenase inhibitor
The effect of SAL (5 x 10 ^M) on cAMP levels was 
determined in uteri from the four phases of the oestrous 
cycle, after treatment with the cyclo-oxygenase inhibitor,
FBF. Tissues were incubated in Tyrode solution containing 
FBF (10 ^M) at 37^0 for 1 hour. After incubation, the tissues 
were transferred to Tyrode solution containing FBF and SAL 
for 1 minute, and then immediately subjected to cAMP analysis.
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E. MEASUREMENT OF CALCIUM FLUXES IN THE UTERUS
The Final determinant of smooth muscle motility is the
level of intracellular free calcium (Ca^^), which is
regulated by three processes - influx, efflux and intracellular
binding. The influence of ovarian hormones on Ca^^ movement
was investigated by studying the influx and efflux of tracer
calcium (^^Ca^^) in uteri from four phases of the oestrous
cycle and from ovariectomized rats. The effect of an
4 5 24-adrenoceptor agonist on Ca fluxes was also examined.
(a) Determination of optimum tracer concentration for
4 ^ 2 +Ca flux experiments
Animals in the oestrus (oestrogen dominated) and 
metoestrus (progesterone dominated) phases were used. 1 cm 
lengths of each uterine horn were blotted, weighed and 
impaled on stainless steel rods. Tissues were incubated 
in Tyrode solution at 37°C for 1 hour. After incubation, 
tissues were transferred to beakers containing the following 
dilutions of ^^Ca^"*” — 0.0005, 0.005, 0.05, and 5 ^Ci/ml 
in Tyrode solution at 37°C for 2 minutes. Tissues were 
then removed, blotted and rinsed for 5 seconds in each of 
five successive beakers containing 50 ml of Tyrode solution 
at 37°C. Tissues were blotted dry and digested in 1 ml 
of 4M potassium hydroxide (KOH) at 60 C for 2 hours. 10 ml 
of scintillant ES 299 were added to each sample which was
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counted for radioactivity in a Packard Tri-Carb liquid 
scintillation spectrometer. Quenching in each sample was 
estimated by using the internal standard method (Peng,
1977)» Tissue ^^Ca^^ was expressed as disintegrations 
per minute (d.p.m.) per wet weight of tissue.
(b) Measurement of ^^Ca^^ efflux in uteri from four phases 
of the oestrous cycle and in ovariectomized animals
Animals were killed, and the phases of the oestrous
cycle identified. Samples were prepared as described above.
After incubation, tissues were transferred to a conical flask
containing ^^Ca^^ (2 ^Ci/ml) in 25 ml of Tyrode solution
at 37°C for 2 hours. The ^^Ca^^ concentration was chosen
on the basis of results from Section E.(a). After loading 
45 2 +with Ca , tissues were rinsed for 5 seconds in a large 
volume of Tyrode solution (25 ml/tissue) at 37°C. At 5 
minute intervals, tissues were sequentially passed through 
a series of vials containing 2 ml of Tyrode solution at 
37°C. 10 ml of scintillant ES 299 were added to each efflux
sample and counted for radioactivity.
At the end of the efflux experiment, each tissue was 
blotted dry and digested in 1 ml of 4M KOH at 60^C for 
2 hours. 10 ml of scintillant were added to each sample 
and counted for radioactivity. Quenching in each sample 
was estimated by the internal standard method.
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Calculations;
Decline of tissue ^^Ca^^ was expressed as disintegrations 
per minute per milligramme wet weight of tissue (d.p.m./mg 
wet wt.), and plotted against time.
The rate constant of ^^Ca^^ loss was calculated 
according to Deth (1978).
Rate Constant = tissue during collection Interval
Ca in tissue before collection interval.
(c) Effect of a P-adrenoceptor agonist on ^^Ca^^ efflux
The effect of P-receptor agonist, SAL on ^^Ca^^ efflux 
was investigated in uteri from the oestrus (oestrogen dominated) 
and metoestrus (progesterone dominated) phases of the oestrous 
cycle. SAL, at a concentration of 3 x 10 ^M, which had 
produced maximum inhibition in isolated uterine horn 
preparations, was present in the Tyrode solution during the 
63-70 minutes period of efflux.
The effect of SAL was also examined in preparations in 
which KCl (3 X 10 ^M) was present in the Tyrode solution 
during the 3O-8O minutes period of efflux.
(d) Measurement of ^^Ca^* influx in uteri from four phases 
of the oestrous cycle and in ovariectomized animals
Animals were killed, and the phase of the oestrous 
cycle identified. Samples were prepared as described above. 
After incubation, tissues were transferred to a beaker 
containing ^^Ca^^ (0.25 ^Ci/ml) in 100 ml of Tyrode solution
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at 37^C. The ^^Ca^^ concentration was chosen on the basis 
of results from Section E.(a). At l/2, 1, 3, 10, 20, 40,
80 and l60 minute intervals, tissues were removed from the 
radioactive solution, blotted and rinsed (3 seconds) in 
each of five successive beakers containing 30 ml of Tyrode 
solution at 37°C. Tissues were then blotted dry and digested 
in 1 ml of 4M KOH at 60°C for 2 hours. 10 ml of scintillant 
were added to each sample and counted for radioactivity. 
Quenching in each sample was estimated by the internal 
standard method.
Calculations
43 2 +The uptake of Ca by tissue is expressed in terms 
of space values or distribution volumes (Kroeger, Marshall 
& Bianchi, 1975).
45ca2+ space (ml/g tissue) = tissue'* -----------
bathing solution Ca (c.p.m./ml)
c.p.m. = counts per minute.
This calculation is based on the assumption that the 
ratio of ^^Ca^* to non-tracer Ca^^ ions entering the tissue 
is identical with the ratio of the same ions in solution.
This is equivalent to assuming homogeneity of distribution 
of tracer to non—tracer Ca^^ ions in interstitial fluid, 
and no difference in penetration of the two ions into the 
tissue.
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43 2 +The Ca . space values were then converted to Uptake 
units (^mol/g wet weight of tissue).
^^Ca^^ estimate of total tissue Ca^^ (y.mol/g) =
^^Ca^* space (ml/g) x concentration of non-tracer Ca^^ (^mol/ml)
(e ) Effect of a P-adrenoceptor agonist on ^^Ca^^ influx
U'^  2 +The effect of P-receptor agonist SAL on Ca influx 
was investigated in uteri from animals in the metoestrus and 
dioestrus phases. SAL (3 x 10 ^M) was present in the Tyrode 
solution containing ^^Ca^* (0.23 jiCi/ml) for the duration of 
the influx experiments.
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F. CHEMICALS AND DRUGS
Acetylcholine chloride
DL-Adrenaline bitartrate
Ascorbic acid
Azapetine phosphate
BW 753c 3-amino-l-(rn- 
trifluoromethyl )-phenyl-2- 
pyrazolone
Calcium chloride
Desmethylimipramine hydrochloride 
Glucose
Histamine acid phosphate 
Magnesium chloride 
Mepyramine maleate 
Methylene blue 
L-Noradrenaline bitartrate 
DL-Normetanephrine hydrochloride 
Papaverine sulphate 
Potassium chloride 
Potassium hydroxide 
DL-Propanolol hydrochloride 
Salbutamol sulphate 
Scintillant ES 299 
Sodium bicarbonate 
Sodium chloride
Sodium dihydrogen orthophosphate 
Sodium flurbiprofen dihydrate 
Theophylline
Sigma
Sigma
B.D.H.
Roche
I.e.I. 
B.D.H.
Geigy 
Formachem 
B. D. H.
M & B 
M & B 
B.D.H.
Sigma
Sigma
B.D.H.
Koch-Light 
Analar 
I.e.I.
Glaxo
Amersham
Koch-Light
Koch-Light
Analar
Boots
Sigma
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4 5 /Calcium (1 mCi as calcium
chloride solution) - Amersham
Cyclic AMP radioimmunoassay 
kit (TRK 432) containing 
Tris/EDTA buffer, [8 - 
adenosine 3'5'-cyclic phosphate 
(5 p.Ci), adenosine 3'5'-cyclic 
phosphate standard, binding 
protein purified from bovine
muscle and charcoal adsorbent - Amersham
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G. STATISTICS
All values given are mean - standard error of the 
mean. Students t-tests were carried out to compare results. 
In diagrams and tables * represents p <  0.05; ** represents 
p <  0.01; and *** represents p <  0.001.
EC^q values were derived from individual dose-response 
curves. pD^ values = negative log^^^ EC^^.
RESULTS
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I. ISOLATED UTERINE HORN PREPARATIONS 
A. Responses to acetylcholine
—  8Acetylcholine (ACh), in the concentration range 10 M 
-4
to 3 X 10 M, produced a dose-related contraction of the 
rat uterus in all phases of the oestrous cycle, and in 
ovariectomized animals. The mean maximum tension developed 
to ACh under these conditions varied (Table 3)* Within the 
oestrous cycle, the highest maximum tension was achieved in 
oestrus and the lowest in dioestrus , while in ovariectomized 
rats, the maximum tension was less than in dioestrus .
Despite the marked variation in the maximum tension developed 
to ACh, the sensitivity of the preparations to ACh was similar 
in all phases of the oestrous cycle, and after bilateral 
ovariectomy. There was no variation in potency as measured 
by pD^ values (Table 3)-
Since the tension induced by ACh varied, a dose-response 
curve was required in each experiment and the dose which 
produced approximately 60%-70% of the maximum was then used 
as the standard. Thus, agonist inhibitory effects could be 
measured as a reduction of this standard ACh response. The 
response to the standard dose of ACh at the end of each 
experiment was not significantly different from that at the 
beginning.
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B- Responses to adrenoceptor agonists in the four phases 
of the oestrous cycle
The criteria used for the choice of the agonists were 
based on their physiological and pharmacological importance.
The endogenous catecholamines - noradrenaline (n a ) and 
adrenaline (ADR) are the adrenergic neurotransmitter and 
the adrenal hormone respectively, and both activate a— and P— 
adrenoceptors. The non-catecholamine salbutamol (SAL) is, 
however, selective for P-adrenoceptors of the p^-subtype.
Dose-response curves and pD^ values for the agonists 
in proestrus, oestrus, metoestrus and dioestrus are shown 
in Figures 2 to 5, and Table 4 respectively.
(a) Proestrus (Figure 2)
NA (10"^M - 10“\ ), ADR (lO"^^M - 3 x 10“^M) and SAL
(1.3 X  10”^M -  1.3 X  10”^M) produced dose-related inhibition
of the standard ACh-induced contraction. The maximum degrees 
of inhibition produced by NA was 20^, while for both ADR 
and SAL, it was approximately 30^. ADR had the highest pD^ 
value, whilst NA had the lowest value (Table 4).
(b) Oestrus (Figure 3)
NA (lO"^M -  3 X  10”^M), ADR (lO M - 10 ^M) and SAL
(1 .^ X 10”^M - 3 X 10”^M) produced dose-related inhibitii
of the standard ACh-induced contraction. The maximum degr, 
of inhibition produced by NA and ADR (20# and 30#, respectively)
on
ees
Fig. 2 : Log. dose-response curves to noradrenaline,
(a), adrenaline, (b). and salbutamol, (c) in 
the rat isolated uterus in proestrus; controls; 
in presence of azapetine (AZA, 10”^M); in 
presence of desipramine (DMI, 10“^^) and nor- 
metanephrine (NMN, IO-^m); in presence of AZA 
with DMI and NMN (all at 10“^M). Number of 
observations in brackets.
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Fig. 3 : Log. dose-response curves to noradrenaline,
(a), adrenaline, (b) and salbutamol, (c) in the 
rat isolated uterus in oestrus: controls; in 
presence of azapetine (AZA. 10"^M); in presence 
of desipramine (DMI, 10“^M) and normetanephrine 
(NMN, 10“^M) ; in presence of AZA with DMI and 
NMN (all at 10”°M) . Number of observations in 
brackets.
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Fig. 4 : Log. dose-response curves to noradrenaline, (A),
adrenaline, (b) and salbutamol, (c) in the rat 
isolated uterus in metoestrus: controls; in 
presence of azapetine (AZA. 10“^M) ; in presence 
of desipramine (DMI, IQ-^M) and normetanephrine 
(NMN, 10~^M); in presence of AZA with DMI and 
NMN (all at 10”°M). Number of observations in 
brackets.
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Fig. 5 : Log. dose-response curves to noradrenaline, (a ),
adrenaline, (b) and salbutamol, (c) in the rat 
isolated uterus in dioestrus: controls; in 
presence of azapetine (AZA. 10"^N); in presence 
of desipramine (DMI, 10”^m) and normetanephrine 
(NMN, 10“^ ) ;  in presence of AZA with DMI and 
NMN (all at 10"^M). Number of observations in 
brackets.
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were similar to those achieved in proestrus, but for SAL, 
a greater degree of inhibition was obtained (approximately 
709 )^. ADR had the highest pD^ value, whilst SAL had the 
lowest value (Table 4).
(c) Metoestrus (Figure 4)
NA (3 X 10"^M - 10 ADR(10"^°M - 10“^M) and SAL
(1.5 X 10 - 5 X 10 ^M) produced dose-related inhibition
of the standard ACh-induced contraction. The maximum degrees 
of inhibition produced by NA and ADR were approximately 40% 
and 30%, respectively. In contrast, a complete inhibition 
of the ACh contraction was observed with SAL. ADR had the 
highest pDg value, whilst NA had the lowest value (Table 4).
(d) Dioestrus (Figure 5)
NA(3 X 10~^M - 10“^M), ADR (lO"^^M - 10"^m) and SAL 
(1.3 X 10 ^M - 1.3 X 10 ^M) produced dose-related inhibition 
of the standard ACh-induced contraction. The maximum degrees 
of inhibition produced by NA, ADR and SAL, were approximately 
30%, 60^ and respectively. ADR had the highest pD^
value, whilst NA had the lowest value (Table 4).
The degrees of inhibition produced by NA, ADR and SAL, 
and their corresponding pD^ values varied throughout the 
oestrous cycle. ADR had the highest, and NA the lowest pD^ 
value in all phases except oestrus, where SAL was the least 
potent.
— 8l —
C. Responses to adrenoceptor agonists in the presence of 
an g-receptor antagonist and uptake inhibitors in the 
four phases of the oestrous cycle
The observed differences in both potency and degree of 
inhibition produced by the agonists during the oestrous 
cycle might have been due to;
(i) the presence of a-excitatory receptors, which could 
oppose the inhibition produced by NA and ADR. Indeed, 
there was some evidence for this effect as these drugs 
produced motor responses in some phases of the oestrous 
cycle.
(ii)the presence of avid amine removal mechanisms into 
neuronal and/or non-neuronal tissues, which could affect 
the responses to all the agonists.
Therefore, three series of experiments were performed 
in the presence of: (a) an a-receptor antagonist (b) inhibitors
of both amine removal mechanisms, and (c) an a-receptor 
antagonist, and inhibitors of both amine removal mechanisms.
1. Motor response
In proestrus and oestrus, both NA and ADR in the 
concentration range 10 ^M to 3 x 10 ^M, produced small 
contractile responses. Unlike the ACh motor responses 
which were rapid in onset and sustained, the NA and ADR 
motor responses had a slow onset, with a latency of 10 seconds
- 82 -
and a duration of only 10 seconds. Generally, the motor 
responses were not dose-related, and were abolished by the 
a-receptor antagonist, azapetine (lO ^M) (Fig. 6).
2. Inhibitory responses to NA. ADR and SAL in the presence 
of an a-receptor antagonist
In the first series of experiments, the inhibitory 
responses were re-examined in the presence of azapetine 
(AZA, 10 ^M) which was chosen since it had no effect on the 
ACh-induced contraction (Digges, I980).
Dose-response curves and pD^ values for the agonists 
in the presence of AZA, in proestrus, oestrus, metoestrus 
and dioestrus are shown in Figures 2 to 3, and Table 3 
respectively.
(a) Proestrus (Figure 2)
AZA enhanced significantly the maximum degree of 
inhibition produced by both NA (p < O.Ol) and ADR (p < 0.03)• 
For ADR only, there was in addition, a significant (p < O.O3) 
shift in the dose-response curves to the right, at the lower 
concentrations. In contrast, AZA had no significant effect 
on SAL dose-response curves. Compared with the control 
value, there was a significant increase (p < O.OOl) in the 
pD^ value for ADR in the presence of AZA, but there were no 
significant differences in the pD^ values for NA and SAL 
(Table 3).
Fig. 6 ; Isometric responses to acetylcholine (ACh) in
the rat isolated uterus in oestius, and inhibition 
of these responses by noradrenaline (NA). ACh (3 x 
10”^M) added at A; NA added at arrows; Wash out @  
Upper trace (a), control; lower trace (b), in 
presence of azapetine (10“°M).
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(b) Oestrus (Figure 3)
AZA enhanced significantly the maximum degree of 
inhibition produced by both NA (p < O.OOl) and ADR (p <  O.O5). 
As in proestrus, there was a significant (p <  O.O5) shift 
in the ADR dose—response curves to the right, at the lower 
concentrations. AZA had no significant effect on the dose- 
response curves to SAL. Compared with the control value, 
there was a significant decrease (p < O.OOl) in the pD^ 
value for NA in the presence of AZA, but there were no 
significant differences in the pD^ values for ADR and SAL 
(Table 5).
(^ c) Metoestrus (Figuré 4)
AZA enhanced significantly (p < O.O5 ) the maximum 
degree of inhibition produced by ADR. As in proestrus and 
oestins, there was a significant (p <  O.Ol) shift in the ADR 
dose—response curves to the right, at the lower concentrations 
In contrast, AZA had no significant effect on NA and SAL 
dose—response curves. Compared with the control value, 
there was a significant increase (p < O.OOl) in the pD^ 
values for ADR in the presence of AZA, but there were no 
significant differences in the pD^ values for NA and SAL 
(Table 5).
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(d) Dioestrus (Figure 3)
In the presence of AZA, the ADR dose—response curve 
was shifted significantly (p < O.OOl) to the right, at the 
lower concentrations. However, the maximum degree of 
ii^^ibition produced by all three agonists was unaffected 
by AZA treatment. As in metoestrus, AZA had no significant 
effect on NA and SAL dose-response curves. There were no 
significant differences in the pD^ values for the agonists, 
in the presence of AZA (Table 3).
a-receptor antagonism increased the maximum degree of 
inhibition produced by NA and ADR, but had no effect on 
SAL responses. Paradoxical shifts in the ADR dose-response 
curve to the right, at the lower concentrations, were observed 
in all phases of the oestrous cycle. a-receptor antagonism 
also produced changes in pD^ values which reached significance 
for ADR (proestrus and oestrus) and NA (oestrus).
3. Inhibitory responses to NA. ADR and SAL in the presence 
of inhibitors of neuronal and extraneuronal uptake 
mechanisms
In the second series of experiments, desipramine (DMI, 
10"^M) and normetanephrine (NMN, 10“^M), were used to inhibit 
neuronal and extraneuronal uptake, respectively.
Dose-response curves and pD^ values for the agonists 
in the presence of DMI and NMN, in proestrus, oestrus, 
metoestrus and dioestrus are shown in Figures 2 to 3, and 
Table 6 respectively.
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(a) Proestrus (Figure 2)
DMI and NMN shifted ADR and SAL dose-response curves 
to the left, and enhanced significantly (p < O.OOl) their 
maximum degree of inhibition. SAL, now produced complete 
inhibition of the ACh-induced contraction. For NA, only 
the maximum degree of inhibition was enhanced significantly 
(p <  O.Ol). There were no significant differences in the 
pD^ values for the agonists, in the presence of DMI and 
NMN (Table 6).
(b) Oestrus (Figure 3)
DMI and NMN shifted NA, ADR and SAL dose-response curves 
to the left, and enhanced significantly (p < O.OOl) their 
maximum degree of inhibition. For ADR and SAL, complete 
inhibition of the ACh-induced contraction was achieved.
Compared with control values, there were significant increases 
(p <  O.OOl) in the pD^ values for ADR and SAL in the presence 
of DMI and NMN, but there was no significant difference in 
the pD^ value for NA (Table 6).
(c) Metoestrus (Figure 4)
DMI and NMN shifted NA, ADR and SAL dose-response curves 
to the left, and enhanced significantly (p < O.OOl) their 
maximum degree of inhibition. SAL, now produced complete 
inhibition of the ACh-induced contraction. Compared with 
the control value, there was a significant increase (p <  O.OOl)
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in the pD^ value for NA in the presence of DMI and NMN, 
but there were no significant differences in the pD^ values 
for ADR and SAL (Table 6).
(d) Dioestrus (Figure 5)
DMI and NMN shifted NA, ADR and SAL dose-response 
curves to the left, and enhanced significantly (p < O.OOl) 
their maximum degree of inhibition. For ADR and SAL, 
complete inhibition of the ACh—induced contraction was 
achieved. There were no significant differences in the pD^ 
values for the agonists, in the presence of DMI and NMN 
(Table 6).
Blockade of agonist removal mechanisms increased the 
maximum degree of inhibition produced by the three agonists 
in all phases of the cycle. The dose-response curves to 
these agonists were also shifted to the left, except for 
NA in proestrus. Shifts in the dose-response curves were, 
however, not reflected in corresponding changes in agonist 
pD^ values since significant increases were achieved in 
only oestrus and metoestrus.
k. Inhibitory responses to NA. ADR and SAL in the combined 
presence of both an a-receptor antagonist and inhibitors 
of neuronal and extraneuronal uptake mechanisms
In the third series of experiments, both a-receptor 
activity, and neuronal and extraneuronal uptake mechanisms
- 90 -
were prevented with AZA (iO'^M), DMI (10‘^M) and NMN (10”^M), 
respectively,
Dose-response curves and pD^ values for the agonists 
in the presence of these antagonists, in proestrus, oestrus, 
metoestrus and dioestrus are shown in Figures 2 to 3, and 
Table 7 respectively.
(a) Proestrus (Figure 2)
The combined antagonists shifted NA, ADR and SAL dose- 
response curves to the left, and enhanced significantly 
(p <  O.OOl) their maximum degree of inhibition. SAL gave 
a complete inhibition of the ACh-induced contraction.
Compared with the control value, there was a significant 
increase (p <  O.OOl) in the pD^ value for ADR in the presence 
of the combined antagonists, but there were no significant 
differences in the pD^ values for NA and SAL (Table 7)«
(b) Oestrus (Figure 3)
The combined antagonists shifted NA, ADR and SAL dose- 
response curves to the left, and enhanced significantly 
(p <  O.OOl) their maximum degree of inhibition. ADR and 
SAL gave complete inhibition of the ACh-induced contraction. 
There were no significant differences in the pD^ values for 
the agonists in the presence of the combined antagonists 
(Table 7).
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(c) Metoestrus (Figure k)
The combined antagonists shifted NA, ADR and SAL dose- 
response curves to the left, and enhanced significantly 
(p < O.OOl) their maximum degree of inhibition. NA and SAL 
gave complete inhibition of the ACh—induced contraction. 
Compared with control values, there were significant increases 
(p ^  O.OOl) in the pD^ values for all three agonists, in 
the presence of the combined antagonists (Table 7).
(d) Dioestrus (Figure 5)
The combined antagonists shifted NA and SAL dose-response 
curves to the left, and enhanced significantly (p <  O.OOl) 
their maximum degree of inhibition. ADR dose-response curve 
was shifted to the right at the lower concentrations, and like 
NA and SAL, the maximum degree was enhanced significantly 
(p <  O.OOl). ADR and SAL gave complete inhibition of the 
ACh-induced contraction. There were no significant differences 
in the pD^ values for the agonists in the presence of the 
combined antagonists (Table 7)»
In the presence of combined a-receptor and uptake^^ 
and uptake^ antagonists, the meiximum degrees of inhibition 
produced by NA, ADR and SAL were increased in all phases of 
the cycle. Agonists dose-response curves were also shifted 
to the left, except for ADR in dioestrus, where an opposite 
shift was observed. Generally, the effects produced by the 
combined antagonists were no greater than those achieved in 
the presence of both Uptake^^ and Uptake^ blockade.
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D. Responses to adrenoceptor agonists in uteri from 
ovariectomized animals
Variations in the degree of inhibition produced by NA 
and ADR persisted, even when a—receptors were blocked and/or 
uptake mechanisms were prevented. Since the uterus is under 
different ovarian hormonal influence in the four phases of 
the oestrous cycle, the possibility that the presence of 
the hormones could underlie the differences in adrenoceptor 
agonists responses was investigated,therefore, in rats 
after bilateral ovariectomy. As in intact animals, the 
same three series of experiments were carried out, viz: 
in the presence of (a), an a-receptor antagonist (b), 
inhibitors of both amine removal mechanisms, and (c), an 
a-receptor antagonist, and inhibitors of both amine removal 
mechanisms.
1. Inhibitory responses to NA. ADR and SAL
NA (IQ-^M - 3 X  10”^M), ADR (lO”^^M - 3 x 10”^M) and
11 Q
SAL (1.5 X  10“ M - 5 X  10” M) produced dose-related inhibition 
of the standard ACh-induced contraction (Fig. ?)• In 
contrast with the experiments in uteri from intact animals, 
all three agonists produced complete inhibition of the ACh 
motor response. The mean pD^ values (— S.E.M. ) for NA, ADR 
and SAL were 8.34 - O.06 (n = 6), 9*81 - O .32 (n = 6) and 
10.34 - 0.36 (n = 6) respectively. SAL pD^ values in
Fig. 7 : Log. dose-response curves to noradrenaline, (a),
adrenaline, (b) and salbutamol, (c) in uteri
from ovariectomized rats: controls; in presence 
of azapetine (AZA, 10"^M); in presence of desipramine 
(DMI, 10”^M) and normetanephrine (NMN, 10“^M); in 
presence of AZA with DMI and NMN (all at 10“^M). 
Number of observations in brackets.
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ovariectomized animals were in general, higher than in the 
four phases of the oestrous cycle (see Table 4).
2• Iifhibitory responses to NA, ADR and SAL in the presence 
of an a-receptor antagonist
In the first series of experiments, AZA (10 ^M) shifted 
significantly ADR (p <  O.Ol) and SAL (p<O.OOl) dose-response 
curves to the right (Fig. 7). Compared with the control 
value, there was a significant decrease (p <  O.Ol) in the 
pD^ value for SAL in the presence of AZA, but there were no 
significant differences in the pD^ values for NA and ADR 
(Table 8).
3. Inhibitory responses to NA. ADR and SAL in the presence 
of inhibitors of neuronal and extraneuronal uptake 
mechanisms
In the second series of experiments, DMI (lO ^M) 
and NMN (10""^M) shifted significantly (p <  0.01 ) NA and ADR 
dose-response curves to the left (Fig. ?)• For SAL, only 
the responses to the lower concentrations were enhanced 
significantly (p <  O.OOl) in the presence of DMI and NMN. 
Compared with the control value, there was a significant 
increase (p <  O.OOl) in the pD^ value for ADR in the presence 
of DMI and NMN, but there were no significant differences 
in the pD^ values for NA and SAL (Table 9)«
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^ tonry responses to NA. ADR and SAL in the combined 
presence of both, an a—receptor antagonist and inliibitors 
of neuronal and extraneuronal uptake mechanisms
In the third series of experiments, the combined 
antagonists, i.e. AZA (10”^M), DMI (10”^M) and NMN (lOT^M), 
shifted significantly (p<O.OOl) the SAL dose-response curve 
to the right (Fig. 7)» In contrast, the dose-response curves 
to NA and ADR were unaffected. Compared with the control 
value, there was a significant decrease (p < O.O3) in the 
pD^ value for SAL in the presence of the combined antagonists, 
but there were no significant differences in the pD^ values 
for NA and ADR (Table lO).
All three adrenoceptor agonists produced complete 
inhibition of the ACh-induced contraction in uteri from 
ovariectomized animals suggesting that hormonal influences 
underlie the differences in responses to NA, ADR and SAL.
One possible explanation was that the hormones were 
affecting the adrenoceptors, and thus the variation in the 
degrees of inhibition produced by the agonists would be 
reflected by corresponding changes in their pD^ values.
When the degrees of inhibition and pD^ values were compared 
in the different hormonal states (Figs. 8, 9, lO), no such 
correlation was found. This would suggest that the events 
responsible for the altered agonist responses lay beyond 
the level of receptor activation.
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Pie. 8 : Maximum degrees of inhibition of ACh-induced
contraction produced by noradrenaline in uteri 
in the four phases of the oestrous cycle and after 
ovariectomy, and corresponding pD^ values* Open 
columns = maximum degree of inhibition; filled 
columns = pD^ values. PRO = proestrus; CES = oestrus; 
m e t  = metoestrus; DIO = dioestrus. Number of 
observations in brackets.
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after ovariectomy, and corresponding pD^ 
values. Open columns = maximum degree of 
inhibition; filled columns = pD^ values.
PRO = proestrus; OES = oestrus; MET = metoestrus; 
DIO = dioestrus. Number of observations in 
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E« Responses to adrenoceptor agonists in the presence of a 
cyclo-oxygenase inhibitor in the four phases of the 
oestrous cycle
The possibility that the adrenoceptor agonists were 
causing intramural generation of prostaglandins, which then 
opposed their inhibitory actions was investigated. Prosta­
glandin generation was blocked with the irreversible inhibitor 
of cyclo-oxygenase, flurbiprofen (FBF). FBF (10”^M) had no 
effect on the motor responses to ACh. Dose-response curves 
were constructed to NA, ADR and SAL alone, i.e. Control I 
experiments (See Methods, C.l(b)), and to the three agonists 
in the presence of AZA (lO ^M), DMI (lO ^M) and NMN (lO ^M), 
i.e. Control II experiments (see Methods, C.l(e)).
(a) Proestrus
Dose-response curves and pD^ values for the agonists 
in the absence, and presence of FBF are shown in Figures 11 
to 13, and Tables 11 and 12, respectively.
Noradrenaline (Figure 11)
FBF shifted both Control I and Control II dose-response 
curves to the left, and enhanced significantly (p <  O.OOl) 
their maximum degree of inhibition. In Control II experiments, 
complete inhibition of the ACh-induced contraction was 
achieved. There were no significant differences in both 
Control I and Control II pD^ values for NA, in the presence 
of FBF (Tables 11 and 12).
- 104 -
Proestrus Phase
80-OJV)coQ.
%rc
o
60-
/\£1U
FBF (6)/co 40-
20-
#  Control I (4)
O"— o
I'
10'
I
FBF (6)/
I
**5
/
:--- r
Ï/ ■5
XControl II (6)
10■8 10-7 10-6
Concentration of Noradrenaline (M) Log Scale
Fig. 1 1 ; Log. dose-response curves to noradrenaline ( N A ) ,  
in the rat isolated uterus in proestrus: 
controls, and in presence of flurbiprofen 
( F B F ,  10”^M). Control I  = NA alone; Control II = 
NA, in presence of AZA (10“^M), DMI (10”^M) and 
NMN (IQ-^M). Number of observations in brackets.
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Adrenaline (Figure 12)
FBF shifted both Control I and Control II dose—response 
curves to the left, and enhanced significantly (p < 0.001 
and p <  0.05, respectively) their maximum degree of inhibition. 
In both control experimental conditions, complete inhibition 
of the ACh—induced contraction was achieved. In Control I 
experiments, there was a significant increase (p <  O.OOl) 
in the pD^ values for ADR, in the presence of FBF (Table 11 ).
In contrast, there was no significant difference in the 
Control II pD^ value for ADR (Table 12).
Salbutamol (Figure 13)
FBF shifted significantly (p < O.OOl) both Control I 
and Control II dose-response curves to the left. In Control I 
experiments, FBF also enhanced significantly (p <  O.OOl) the 
maximum degree of inhibition. In Control II experiments, 
there was a significant increase (p < O.OOl) in the pD^ 
value for SAL, in the presence of FBF (Table 12). In contrast, 
there was no significant difference in the Control I pD^ 
value for SAL (Table 11)•
(b) Oestrus
Dose-response curves and pD^ values for the agonists 
in the absence, and presence of FBF are shown in Figures l4 
to 16, and Tables 11 and 12, respectively.
- 108 _
100-,
c
o
Q.in
oc
3:<_)
iD
iZ
c
X
80-
d O ~
40-
20-
Proestrus Phase
(a)
/
i'
FBF (6)/
/
/
I
?
/ ./con"Control I (6)
(b)
10-10 10-9 10' 10-7
FBF (5)
Control II (8)
Concentration of Adrenaline (M) Log Scale
Fig. 12; Log. dose-response curves to adrenaline (ADR), 
in the rat isolated utexnas in proestrus; 
controls, and in presence of flurbiprofen 
(FBF, 10“^M) • Control I = ADR alone; Control II 
ADR, in presence of AZA (10“^M), DMI (10”^M) and 
NMN (10“^M). Number of observations in brackets.
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Fig. 13; Log. dose-response curves to salbutamol (SAL), 
in the rat isolated uterus in proestrus: 
controls, and in presence of flurbiprofen 
(FBF, 10“^M). Control I = S.^ alone; Control II 
SAL, in presence of AZA (lO”^ ) ,  DMI (10”^M) and 
NMN (10“^M). Number of observations in brackets.
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Noradrenaline (Figure l4)
FBF shifted both Control I and Control II dose-response 
curves to the left, and enhanced significantly (p <  O.OOl)
"their maximum degree of inhibition. In Control II experiments, 
complete inhibition of the ACh—induced contraction was 
achieved. There were no significant differences in both 
Control I and Control II pD^ values for NA, in the presence 
of FBF (Tables 11 and 12).
Adrenaline (Figure I3)
FBF shifted the Control I dose-response curve to the 
left, and enhanced significantly (p <  O.OOl) the maximum 
degree of inhibition. However, the Control II dose-response 
curve was unaffected by FBF treatment. In Control I experiments 
there was a significant increase (p <  O.OOl) in the pD^ values 
for ADR, in the presence of FBF (Table 11)• In contrast, 
there was no significant difference in the Control II pD^ 
value for ADR (Table 12).
Salbutamol (Figure I6)
FBF shifted the Control I dose-response curve to the 
left, and enhanced significantly (p <  O.OOl) the maximum 
degree of inhibition. In Control II experiments, only a 
slight but non-significant leftward shift in the dose-response 
curve was achieved at the lower concentrations. In both 
Control I and Control II experiments, there was a significant
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Fig. l4: Log. dose-response curves to noradrenaline (NA), 
in the rat isolated uterus in oestrus: controls, 
and in presence of flurbiprofen (FBF, 10”^M). 
Control I = NA alone; Control II = NA, in presence 
of AZA (10“^M), DMI (10“^M) and NMN (iQ-^M).
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in the rat isolated uterus in oestrus: controls, 
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Fig» l6; Log. dose-response curves to salbutamol (SAL),
in the rat isolated uterus in oestms: controls, 
and in presence of flurbiprofen (FBF, 10”°M). 
Control I = SAL alone ; Control II = SAL, in 
presence of AZA (10”®M), DMI (10”°M) and NMN 
(lO” M). Number of observations in brackets.
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increase (p< O.OOl) in the pD^ values for SAL, in the 
presence of FBF (Tables 11 and 12).
(c ) Metoestrus
Dose-response curves and pD^ values for the agonists 
in the absence, and presence of FBF are shown in Figures 
17 to 19, and Tables 11 and 12, respectively.
Noradrenaline (Figure 1?)
FBF shifted the Control I dose-response curve to the 
left, and enhanced significantly (p<O.OOl) the maximum 
degree of inhibition. In Control II experiments, only a 
slight but non-significant leftward shift in the dose- 
response curve was achieved. In Control I experiments, 
there was a significant increase (p <  O.Ol) in the pD^ 
value for NA, in the presence of FBF (Table ll). In contrast, 
there was no significant difference in the Control II pD^ 
value for NA (Table 12).
Adrenaline (Figure 18)
FBF shifted both Control I and Control II dose-response 
curves to the left, and enhanced significantly (p< 0.001 and 
p <  0.01, respectively) their maximum degree of inhibition.
In both control experimental conditions, complete inhibition 
of the ACh-induced contraction was achieved. In Control I 
experiments, there was a significant increase (p <  O.O5)
in the pD^ values for ADR, in the presence of FBF (Table ll).
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Fig. 17 : Log. dose-response curves to noradrenaline (NA), 
in the rat isolated uteinis in metoestrus: 
controls, and in presence of flurbiprofen (FBF, 
10”^M). Control I = NA alone; Control II =
NA, in presence of AZA (10“^M), DMI (10”^M) and 
NMN (10“^M). Number of observations in brackets.
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Fig, 18; Log. dose-response curves to adrenaline (ADR),
in the rat isolated uterus in metoestrus: controls, 
and in presence of flurbiprofen (FBF, 10“°M).
Control I = ADR alone; Control II = ADR, in presence 
of AZA (lO-^M), DMI (lO-^M) and NMN (lO“% ).
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In contrast, there was no significant difference in the 
Control II pD^ value for ADR (Table 12).
Salbutamol (Figure 19)
FBF shifted significantly (p<O.OOl) both Control I 
and Control II dose-response curves to the left. There 
were no significant differences in both Control I and 
Control II pD^ values for SAL, in the presence of FBF 
(Tables 11 and 12).
(d) Dioestrus
Dose-response curves and pD^ values for the agonists 
in the absence, and presence of FBF are shown in Figures 
20 to 22, and in Tables 11 and 12, respectively.
Noradrenaline (Figure 20)
FBF shifted both Control I and Control II dose-response 
curves to the left, and enhanced significantly (p <  0.001 
and p <  0.01, respectively) their maximum degree of 
inhibition. In Control II experiments, complete inhibition 
of the ACh-induced contraction was achieved. There were no 
significant differences in both Control I and Control II 
pD^ values for NA, in the presence of FBF (Tables 11 and 
12).
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Fig. 19: Log. dose-response curves to salbutamol (SAL),
in the rat isolated uterus in metoestrus: controls, 
and in presence of flurbiprofen (FBF, 10”^M).
Control I = SAL alone; Control II = SAL, in presence 
of AZA (10-°M), DMI (10”^M) and NMN (lO~%).
Number of observations in brackets.
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Fig. 20; Log. dose-response curves to noradrenaline (NA),
in the rat isolated uterus in dioestrus: controls, 
and in presence of flurbiprofen (FBF, 10”^M). 
Control I = NA alone; Control II = NA, in presence 
of AZA (lO-^M), DMI (lO-OM) and NMN (10"^M).
Number of observations in brackets.
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Adrenaline (Figure 21)
FBF shifted the Control I dose-response curve to the 
left, and enhanced significantly (p <  O.OOl) the maximum 
degree of inhibition. In Control II experiments, FBF only 
shifted significantly (p <  O.OOl) the dose-response curve 
to the left. There were no significant differences in 
both Control I and Control II pD^ values for ADR, in the 
presence of FBF (Tables 11 and 12).
Salbutamol (Figure 22)
FBF shifted the Control I dose-response curve to the 
left, and enhanced significantly (p <  O.OOl) the maximum 
degree of inhibition. In Control II experiments only 
responses to the higher concentrations of SAL were enhanced 
significantly (p <  O.Ol). In Control II experiments, there 
was a significant increase (p <  O.OOl) in the pD^ value 
for SAL, in the presence of FBF (Table 12). In contrast, 
there was no significant difference in the Control I pD^ 
value for SAL (Table ll).
Cyclo-oxygenase inhibition shifted the agonist dose- 
response curves to the left, and increased their maximum 
degree of inhibition when no antagonists were present, i.e. 
in Control I experiments. Since the combined antagonists 
(Control II experiments) had already produced leftward 
shifts in the dose-response curves, and increased inhibition, 
cyclo-oxygenase inhibition produced lesser effects in the 
Control II, than in Control I experiments.
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Fig. 21; Log. dose-response curves to adrenaline (ADR), 
in the rat isolated uterus in dioestrus: 
controls, and in presence of flurbiprofen (FBF, 
lO” M). Control I = ADR alone; Control II = ADR, 
in presence of AZA (10”^M), DMI (IO^^M) and NMN 
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Fig. 22; Log. dose-response curves to salbutamol (SAL),
in the rat isolated uterus in dioestrus; controls, 
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Control I = SAL alone; Control II = SAL, in presence 
of AZA (IQ-^M), DMI (10"^M) and NMN (10“^M).
Number of observations in brackets.
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F • Responses to adrenoceptor agonists in the presence of* a 
cyclo-oxygenase inhibitor in uteri from ovariectomized 
animals
Since the ovarian hormones affected the degree of 
inhibition produced by the adrenoceptor agonists, the possible 
role of the prostaglandins was examined in uteri from 
ovariectomized animals. Dose-response curves to the 
agonists were obtained in the absence (Control I experiments), 
and presence (Control II experiments) of the combined 
antagonists and cyclo-oxygenase activity was inhibited with 
FBF (lO'^M).
Dose-response curves and pD^ values for the agonists 
in the absence, and presence of FBF are shown in Figures 
23 to 23, and Table 13, respectively.
Noradrenaline (Figure 23)
FBF shifted significantly (p <  O.OOl) the Control II 
dose-response curve to the left, but had no effect on the 
Control I curve. There were no significant differences in 
both Control I and Control II pD^ values for NA, in the 
presence of FBF (Table 13)*
Adrenaline (Figure 24)
FBF shifted significantly both Control I (p <  O.OOl) 
and Control II (p <  O.O3, higher concentrations only)
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Fig' 23 ; Log. dose-response curves to noradrenaline (n a ) 
in uteri from ovariectomized rats: controls 
and in presence of flurbiprofen (FBF, 10” M). 
Control I = NA alone; Control II = NA, in presence 
of AZA (10”^M), DMI (lO" M) and NMN (10"^M).
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Fig. 2 k : Log. dose-response curves to adrenaline (ADR) 
in uteri from ovariectomized rats: controls
and in presence of flurbiprofen (FBF, 10 M).
Control I = ADR alone, Control II = ADR, in 
presence of AZA (lO” N), DMI (lO” M) and NMN 
(10"^M). Number of observations in brackets.
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dose-response curves to the left. However, the Control II 
dose-response curve was also shifted significantly (p <  O.OOl) 
to the right, at the lower concentrations. In both Control I 
and Control II experiments, there was a significant increase 
(p <  O.Ol) in the pD^ values for ADR, in the presence of 
FBF (Table 13).
Salbutamol (Figure 23)
FBF shifted significantly both Control I (p<0.05) 
and Control II (p <  O.OOl) dose-response curves to the left. 
However, the increases in both Control I and Control II pD^ 
values for SAL in the presence of FBF, were not statistically 
significant (Table 13).
Since the adrenoceptor agonists produced 100^ inhibition 
of the ACh-induced contraction in uteri from ovariectomized 
animals, the effects of FBF could be seen only in terms of 
shifts in the dose-response curves, and changes in pD^ values. 
Cyclo-oxygenase inhibition enhanced agonist responses in 
these uteri suggesting that prostaglandin production induced 
by NA, ADR and SAL was independent of the hormonal status 
of the animal.
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Fig. 25: Log. dose-response curves to salbutamol (SAL) 
in uteri from ovariectomized rats; controls 
and in presence of flurbiprofen (FBF, 10“^Mj. 
Control I = SAL alone; Control II = SAL, in 
presence of AZA (lO“^ ) ,  DMI (IO-^m ) and NMN 
(10“^m ). Number of observations in brackets.
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Responses to histamine in the presence of a cyclo- 
oxygenase inhibitor in the four phases of the oestrous 
cycle
Uterine relaxants other than adrenoceptor agonists may
affect intramural prostaglandin production. Hence, a series
of experiments was carried out using histamine (HIS) which
acts via H^-receptors. The inhibitory effect produced by
HIS was examined in the presence of H^-receptor antagonist,
—8mepyramine (5 x lO” M).
1. Inhibitory responses to histamine
Dose-response curves and pD^ values for histamine are 
shown in Figures 26 and 27, and Table l4, respectively.
(a) Proestrus (Figure 26a )
HIS (lO” M - 3 X lO” M) produced dose-related inhibition 
of the standard ACh-induced contraction with the maximum 
degree of inhibition being approximately hO^o,
(b) Oestrus (Figure 26b )
HIS (10“ M - 3 X lO” M) produced dose-related inhibition 
of the standard ACh-induced contraction with the maximum 
degree of inhibition being approximately 70%.
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(c) Metoestms (Figure 27A)
M — 3 X 10 m ) produced dose—related inhibition 
of the standard ACh—induced contraction with the maximum 
degree of inhibition being approximately 80%*
(d) Dioestrus (Figure 27B)
— 7 Zi
HIS (10 M - 3 X 10 M) produced dose-related inhibition 
of the standard ACh-induced contraction. As in metoestrus, 
the maximum degree of inhibition achieved was approximately 
80^^
2. Inhibitory responses to histamine in the presence of 
a cyclo-oxygenase inhibitor
Dose-response curves to HIS in proestrus, oestrus 
(Fig. 26), metoestrus and dioestrus (Fig. 27) were unaffected 
by FBF treatment. There were no significant differences 
in the pD^ values for HIS in the presence of FBF, in the 
four phases of the oestrous cycle.
Although the maximum degree of inhibition produced by 
histamine varied throughout the oestrous cycle, cyclo- 
oxygenase inhibition did not affect these responses.
Fig. 27: Log. dose-response curves to histamine, in the
rat isolated uterus in metoestrus (c) and dioestrus 
fD) : controls, and in presence of flurbiprofen 
(FBF, 10”^M). Number of observations in brackets.
0}
- 133 -
% inhibition of ACH motor response
ro
o
XT
o O
00
O
O
O
O
00
o
00 o
KH
00o
o
3 O
o
CD 
3
r +
—1 
Û)
r-t — *
—  O
O  I
3  X
O 
—h
ZT
<n
CD
r-+
O
CD
(/)
C
CO
CD
CD
O
I
—  O  
O I “
IÛ CD
CO
o
Û)
o  -
I
V I
o
I “
KM
I##
K)
o •
O
m o
0 0 o o
- n 13 CD
t-f CO
C D o — 1
C D
c
CO
1— 0  h-e-H
- 134 -
H» ^Qsponses to papaverine in the presence of a cyclo-
oxygenase inhibitor in the four phases of the oestrous cycle
Since both the adrenoceptor agonists and histamine acted 
via receptors, the effect of papaverine (PAP), a non-specific 
smooth muscle relaxant, was examined.
1» Inhibitory responses to papaverine
— 7 _ 2i
PAP (3 X 10 M - 10 M) produced dose-related inhibition 
of the standard ACh motor response in all four phases.
The dose-response cuirves and pD^ values for PAP are shown 
in Figure 28, and Table 15, respectively. Unlike the 
adrenoceptor agonists and histamine, PAP produced complete 
inhibition of the ACh-induced contraction in each phase.
2. Inhibitory responses to papaverine in the presence of a
cyclo-oxygenase inhibitor
Dose-response curves to PAP in proestrus, oestrus, 
metoestrus and dioestrus were not affected by FBF treatment 
(Fig. 28). There were no significant differences in the 
pD^ values for PAP in the presence of FBF (Table 15)»
As with HIS , cyclo-oxygenase inhibition did not affect 
PAP responses in the four phases of the oestrous cycle. The 
inability of FBF to modify the responses to HIS and PAP, 
unlike those to the adrenoceptor agonists, suggested that 
an effect on intramural prostaglandin production was not 
initiated by all uterine relaxants.
Fig. 28; Log. dose-response curves to papaverine, in 
the rat isolated uterus in proestrus (a), 
oestrus (b), metoestrus (c) and dioestrus (d) : 
controls, and in presence of flurbiprofen (FBF, 
10“^M). Number of observations in brackets.
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!• Responses to potassium chloride
In order to demonstrate the relaxant effects of drugs 
in the uterus, tone must be induced# Several methods of 
inducing tone are available, and it is possible that the 
means chosen may affect the observed relaxation. Since in 
all experiments described so far tone was induced with ACh, 
this possibility was examined in a series of corresponding 
experiments in which tone was induced with potassium chloride
(k c i ).
In preliminary experiments,the effects of KOI concentrations 
between 3 x 10 M and 10 M were examined in uteri from the 
four phases of the oestrous cycle. The standard concentration 
chosen was 3 x 10”^M, which produced a biphasic contractile 
response with an initial transient phase, and a secondary 
sustained phase lasting for more than 1 hour. The mean 
maximum tension developed to KOI during the secondary sustained 
phase is shown in Table l6. The highest tension was developed 
in oestrus, and the lowest in metoestrus.
Cumulative dose-response curves to the adrenoceptor 
agonist SAL were constructed 13 minutes into the sustained 
phase, until a maximum relaxation of the KCI—induced tone 
was achieved. Of the three adrenoceptor agonists, SAL was 
chosen for the next series of experiments because it is 
selective for i^—adrenoceptors.
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1 • responses to SAL in potassium chloride
depolarized uteri
SAL (l»5 X 10 M - 3 X 10 ^M) produced dose-related 
relaxation of the KOI—induced tone in proestrus, oestrus, 
metoestrus and dioestrus. Mean pD^ values for SAL in KCl- 
depolarized uteri are shown in Table 1?. Corresponding 
values for SAL in experiments using ACh are also shown. 
Compared with the pD^ values in uteri in which tone was 
induced with ACh, there were no significant differences in 
the pD^ value for SAL in KCl-depolarized uteri except in 
dioestrus. These experiments represent the Control I 
situation as described earlier.
2. Inhibitory responses to SAL in the combined presence of 
both an a-receptor antagonist and inhibitors of neuronal 
and extraneuronal uptake mechanisms
Responses to SAL were then examined in the presence 
of all three antagonists — AZA, DMI and NMN, i.e. the 
experiments represented the Control II situation as described 
earlier. Mean pD^ values for SAL in KCl-depolarized uteri, 
in the presence of the combined antagonists are shown in 
Table 18. In comparison with the Control I values, there 
were significant increases (p <  O.OOl) in the pD^ values 
for SAL in metoestrus and dioestrus, in the presence of the 
combined antagonists.
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'J• Responses to SAL in the presence of a cyclo—oxygénase 
inhibitor in potassium chloride depolarized uteri
Both Control I and Control II experiments were repeated 
in the presence of the cyclo-oxygenase inhibitor, FBF (10“^M). 
Figure 29 illustrates a typical experiment obtained under 
the Control II condition, in dioestrus.
Dose-response curves and pD^ values for SAL in the 
absence and presence of FBF in the four phases are shown in 
Figures 30 to 33, and Table 19, respectively.
(a) Proestrus (Figure 30)
FBF shifted significantly (p <  O.OOl) both Control I 
and Control II dose-response curves to the left. In Control I 
experiments, FBF also enhanced significantly (p <  O.OOl) 
the maximum degree of relaxation. In Control II experiments, 
there was a significant increase (p <  O.Ol) in the pD^ value 
for SAL, in the presence of FBF. However, the increase in
the Control I pD^ value for SAL was not statistically
significant (Table 19) •
(b) Oestrus (Figure 31)
FBF shifted significantly (p <  O.Ol) both Control I 
and Control II dose-response curves to the left. In Control I 
experiments, the maximum degree of inhibition was enhanced 
significantly (p <  O.OOl), as in proestrus. In Control II
Fig. 29: Isometric responses to potassium chloride
(k c i , 5 X 10”2m ) , in the rat isolated uterus 
in dioestrus, and relaxation of the KCl- 
induced tone by salbutamol (added at arrows). 
AZA (lO-OM), DMI (IQ-OM) and NMN (10“% )  was 
present in the Tyrode solution throughout the 
experiment. Drugs washed out # Upper trace 
(a), control; lower trace (b), in presence of 
flurbiprofen (lO“%).
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experiments, there was a significant increase (p <  O.Ol) 
in the pD^ value for SAL, in the presence of FBF. However, 
the increase in the Control I pD^ value for SAL was not 
statistically significant (Table I9).
(c) Metoestrus (Figure 32)
FBF shifted significantly both Control I (p <  O.O5) 
and Control II (p <  O.Ol) dose-response curves to the left.
In Control II experiments, there was a significant increase 
(p <  0 .01) in the pD^ value for SAL^ in the presence of FBF.
However, the increase in the Control I pD^ value for SAL
was not statistically significant (Table I9).
(d) Dioestrus (Figure 33)
FBF shifted significantly (p <  O.OOl) the Control II 
dose-response curves to the left. In Control I experiments 
only the responses to the lower concentrations of SAL were 
enhanced significantly (p <  O.Ol). In Control II experiments 
there was a significant increase (p <  O.Ol) in the pD^ 
value for SAL, in the presence of FBF. However, the increase 
in the Control I pD^ value for SAL was not statistically 
significant (Table 19)*
The inhibitory effect and pD^ values for SAL in KCl- 
depolarized uteri were similar to those in which tone was 
induced with ACh. In addition, inhibition of cyclo-oxygenas 
with FBF produced corresponding changes in the dose-response 
curves and pD^ values in the four phases of the oestrous
Fig. 32; Log. dose-response curves to salbutamol (SAL), 
in the rat isolated uterus in metoestrus: 
controls, and in presence of flurbiprofen 
(FBF, 10”^ ) .  Control I = SAL alone; Control 
II = SAL, in presence of AZA (10“^M), DMI 
(10“^M) and NMN (lO“ M). Number of observations 
in brackets.
— 1 A- 8 —
% relaxation of KCl-lnduced tone
O
O
00o cno XrO roo
o
o
o
o
oo
Z3o
CD
3
r-r
-1
CD
I—r
o
CO
00
13
r-r
O
C/5
CD
CJ
c
r +
0)
Û)
CD
r-r
O
(D
CO
O  O
OCO
O
CD
CD
O
O
OOO
00
o
CO
TJ
ZJ
C D
CO
CD
CJl
Fig. 33: Log. dose-response curves to salbutamol (SAL), 
in the rat isolated uterus in dioestrus: 
controls, and in presence of flurbiprofen (FBF, 
10“^M). Control I = SAL alone; Control II =
SAL in presence of AZA (10“®M), DMI (10”^M) and 
NMN (10”^M). Number of observations in brackets.
- 149 -
% relaxation of KCI-lnduced tone
O
O
00o -to ISOo
o
o
o
o
oo
13
o
C D  
Z 3  
r-h 
—1 
0) 
r-h
O
00
o
00
o
Z 3
o o
—h I C D
CD
O)
O)
CT
Oc
r-h
O )
3
O
* kJ
oo
IQ
OC D
O
CÙ C D
C D
O
00
O
00
C D
O
C D
O
C D
C D
C D
•o
I T
C D
C D
C D
- 150 -
cycle. Thus, it would appear that both the observed 
inhibitoiy effect to adrenoceptor agonists, and the 
enhancement produced by cycle—oxygenase inhibition, are 
independent of the method of inducing tone in the uterus.
K. Responses to SAL in the presence of an inhibitor of both 
cyclo-oxygenase and lipoxygenase in the four phases of 
the oestrous cycle
The prostaglandin precursor, arachidonic acid is a 
common substrate for both cyclo-oxygenase and lipoxygenase, 
and products of the latter pathway (i.e. the leukotrienes) 
may also be involved in uterine motility (Fig. 54). Indeed, 
by blocking the cyclo-oxygenase pathway, the substrate will 
be available solely for conversion to the leukotrienes. The 
possibility that the leukotrienes could be affecting the 
adrenoceptor agonists responses was, therefore investigated 
in a series of experiments. 3-amino-l-(m-trifluoromethyl)- 
phenyl-2-pyrazolone (B¥ 755C, 10"”^ M), a dual inhibitor of 
both cyclo-oxygenase and lipoxygenase activities was used. 
Uterine tone was induced with KCl (5 x 10 ^M), and all three 
antagonists were present i.e. these experiments were of the 
Control II type.
Dose-response curves and pD^ values for SAL in the 
absence, and presence of B¥ 735C in the four phases are 
shown in Figures 35 to 38, and Table 20, respectively, in 
which FBF values are included for comparison. B¥ 755C
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IlEi 34 : Generation of prostaglandins and leukotrienes 
from arachidonic acid by cyclo-oxygenase and 
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inhibits cyclo-oxygenase, while B¥ 753C inhibits 
both cyclo-oxygenase and lipoxygenase activities
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Fig. 35; Log. dose-response curves to salbutamol in the 
rat isolated uterus in proestrus: control, and 
in presence of FBF (lp-%) and BW 755C (IQ-^m ).
AZA (lO-^M), DMI (10-°M) and NMN (IQ-^m ) present 
in the Tyrode solution throughout the experiment. 
Number of observations in brackets. Note reversal 
of the ordinate scale.
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Fig. 36; Log. dose-response curves to salbutamol in the 
rat isolated uterus in oestrus: control, and
in presence of FBF (10“®M) and BW 755C (iQ-^M). 
AZA (10”°M), DMI (10“°M) and NMN (lO-^M) present 
in the Tyrode solution throughout the experiment 
Number of observations in brackets.
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Fig. 37; Log. dose-response curves to salbutamol in the
rat isolated uterus in metoestrus: control and
in presence of FBF (10“ M) and BW 755C (10“5m ). 
AZA (10”^M), DMI (10”°M) and NMN (10“^M) present 
in the Tyrode solution throughout the experiment. 
Number of observations in brackets.
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Fig. 38; Log. dose-response curves to salbutamol in the 
rat isolated uterus in dioestrus; control, and 
in presence of* FBF (lO" M ) and BW 735C (10”3m ). 
AZA (10“^M), DMI (10“^M) and NMN (lO-^M) present 
in the Tyrode solution throughout the experiment 
Number of observations in brackets.
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shifted the SAL dose-response curves to the left, and 
increased the pD^ values in the four phases of the oestrous 
cycle. All changes were significant at p <  0.01 or greater.
As can be seen from the figures and Table 20, BW 733C 
produced the same effect as did FBF, which would suggest 
that products of the lipoxygenase pathway are not involved 
in adrenoceptor agonists inhibitory responses in the uterus
— 13S —
I I '  ADENOSINE 3* 5 *  CYCLIC MONOPHOSPHATE ASSAY EXPERIMENTS 
IN THE FOUR PHASES OF THE OESTROUS CYCLE
Inhibition of intraimiral prostaglandin production reduced 
the variation between the adrenoceptor agonists in the 
different phases of the oestrous cycle and in ovariectomized 
animals but did not abolish it completely. Moreover, agonist 
effects on prostaglandin production appeared independent of 
hormonal influences. Thus the remaining variation may be 
due to the ovarian hormones. Since these have been reported 
to alter adenosine 3'5* cyclic monophosphate (cAMP) levels 
in the rat uterus (Kishikawa, I98I), and -adrenoceptor 
agonists act via increased levels of cAMP, uterine levels of 
cAMP were examined in the four phases.
Basal cAMP levels were first measured in uteri from the 
four phases, and the effects of the combined antagonists 
(i.e. the Control II situation described previously) and 
SAL examined. A concentration of 3 x 10 SAL was used 
because it produced the maximum inhibitory effect in isolated 
uterine horn preparations.
1. Basal cAMP levels
The basal cAMP levels in uteri from proestrus, oestrus, 
metoestrus and dioestrus are shown in Figure 39» There 
were no statistically significant differences in basal cAMP 
content in the four phases. Addition of the combined
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of tissue) in the rat isolated uterus, in the 
four phases of the oestrous cycle. P = proestrus; 
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antagonists - AZA (lO”S ) ,  DMI (10“^M) and NMN (lO”^M), 
produced no significant differences in basal cAMP levels, 
and did not alter the effects of SAL on these levels.
2. Effect of SAL on cAMP levels
SAL (5 X 10 ^M) produced significant increases (p <  O.OOl) 
in cAMP content which were similar in all four phases (Fig. 
kO) .
3• Effect of a cyclo-oxygenase inhibitor on cAMP levels
Prostaglandins have been shown to alter cAMP metabolism 
in the rat uterus (Krall, Barrett, Jamgotchian & Korenman, 
1984). Therefore, the effect of cyclo-oxygenase inhibition 
on basal cAMP levels was investigated and the effects of SAL 
re-examined in preparations in which prostaglandin production 
had been inhibited. Addition of the combined antagonists 
(i.e. Control II situation) did not alter the effects of 
FBF (10"”^ M) alone, or in combination with SAL.
The effects of FBF on basal cAMP levels are shown in 
Figures 4l and 42. There were no statistically significant 
differences in cAMP content in the presence of FBF, in any 
of the phases.
4. Effect of SAL on cAMP levels in uteri pretreated with a 
cyclo-oxygenase inhibitor
In a series of experiments, the effect of SAL (3 x 10 M )
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Fig. 40; Effect of salbutamol (SAL) on basal cAMP levels
(expressed as pmol/g wet weight of tissue) in the 
four phases of the oestrous cycle. PRO = proestrus; 
OES = oestrus; MET = metoestrus; DIO = dioestrus. 
Filled columns = controls; hatched columns = in 
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Fig. 4l: Effect of flurbiprofen (FBF) on basal cAMP levels 
(expressed as pmol/g wet weight of tissue) in the 
rat isolated uterus in proestrus (a), and oestrus 
(b). Open columns = controls; hatched columns = 
in presence of FBF (10“^M). Number of observations 
in brackets.
Fig. 42; Effect of flurbiprofen (FBF) on basal cAMP levels 
(expressed as pmol/g wet weight of tissue) in the 
rat isolated uterus in metoestrus (a), and dioestrus 
(b). Open columns = controls; hatched columns = 
in presence of FBF (IO-^M). Number of observations 
in brackets.
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was examined in preparations pretreated with FBF (10”^M).
The results obtained are shown in Figures 43 to 46. In 
the presence of FBF, SAL produced significant increases 
(p <  O.OOl) in cAMP content in uteri from all four phases, 
but the increases were not different from those in which 
prostaglandin production had not been inhibited.
Basal cAMP levels and the increases induced by SAL were 
similar in all four phases of the cycle. Cyclo-oxygenase 
inhibition had no effect on basal cAMP levels, nor on the 
ability of SAL to increase tissue cAMP content. This would 
suggest a limited role for cAMP in the observed variation 
in adrenoceptor agonists inhibitory effects during the 
oestrous cycle.
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Fig. 43: Effect of salbutamol (SAL) on cAMP levels (pmol/g 
wet weight of tissue) in the rat isolated uterus 
in proestrus: before, and after treatment with
FBF (lO“ M). Filled columns = controls; open 
columns = in presence of SAL (5 x 10“^M). Number 
of observations in brackets.
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Fig. 44; Effect of salbutamol (SAL) on cAMP levels (pmol/g 
wet weight of tissue) in the rat isolated uterus 
in oestrus: before, and after treatment with FBF
(lO“ M). Filled columns = controls; open columns = 
in presence of SAL (5 x 10"^M). Number of observation 
in brackets.
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Pig. 45: Effect of salbutamol (SAL) on cAMP levels (pmol/g 
wet weight of tissue) in the rat isolated uterus 
in metoestrus: before and after treatment with 
FBF (10"^M). Filled columns = controls; open 
columns = in presence of SAL (5 x IQ-^M). Number 
of observations in brackets.
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Fig. 46; Effect of salbutamol (SAL) on cAMP levels (pmol/g 
wet weight of tissue) in the rat isolated uterus 
in dioestrus: before, and after treatment with
FBF (IO-^M). Filled columns = controls; open 
columns = in presence of SAL (5 x 10” M). Number 
of observations in brackets.
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III' RADIOACTIVE CALCIUM EXPERIMENTS
Since adrenoceptor agonist effects on prostaglandin
production and cAMP metabolism did not account wholly for
the observed variation in their inhibition, a third
possibility was then considered. Hormonally induced changes
in calcium (Ca^*) movements may play an indirect role in
the altered responses because the final determinant of
smooth muscle motility is the availability of intracellular 
2+ 2+free Ca • Ca movements were studied in uteri from four 
phases of the oestrous cycle, and in ovariectomized animals.
Z4.5 2 +
1. Determination of Ca concentration for efflux and 
influx experiments
The optimum tracer concentration to be used for efflux
and influx studies was determined in preliminary experiments.
Zi EC 2 +
Tissue Ca content was measured at different tracer 
concentrations in oestrus and metoestrus, which represented 
the extremes of the oestrous cycle, i.e. an oestrogen dominated 
and a progesterone dominated phase, respectively (Fig. 47)»
45 2+In both phases, tissue uptake of Ca was concentration
Z4.5 2 +
dependent and exhibited a similar pattern. Tissue Ca 
increased gradually reaching a plateau at O.O5 v-Ci/ml.
Above 0.05 i^Ci/ml, there was a very sharp rise in tissue 
^^Ca^* up to 5 v-Ci/ml.
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The plateau was attributed to attainment of equilibrium
4-5 2+
with the bathing medium Ca at the low tracer concentrations. 
The marked increase in tissue ^^Ca^* at the higher 
concentrations reflected Ca^* binding within the extracellular 
space. In order to minimize this non-specific binding of 
tracer in the extracellular space, a concentration of
0.25 p-Ci/ml was, therefore, chosen for influx experiments. 
Moreover, it would be difficult to measure small changes 
in tracer influx against a high background count. For 
efflux experiments, a concentration of 2 |iCi/ml was chosen 
in order to ensure adequate loading of cells. In this case, 
some tracer will also be bound in the extracellular space.
2. ^^Ca^^ efflux in the four phases of the oestrous cycle
^^Ca^'*’ efflux in uteri from animals in proestrus, oestrus,
metoestrus and dioestrus was biphasic (Fig. 48). There was
Ac 2 +
an initial rapid decline in tissue Ca in the first 30 
minutes of efflux, followed by a slower decline until 
equilibrium was achieved after about 50 minutes. Uteri 
from all four phases showed a similar pattern of decline of 
tissue but efflux in metoestrus was significantly
lower (p <  0.001) than in the other three phases.
The rate constant of ^^Ca^^ loss (i.e. ^Ca leaving
45 2+
tissue during collection interval divided by Ca in the
tissue at the beginning of the interval), was determined
45 2 +
for each phase (Fig. 49). As with the ^Ca efflux curves, 
a biphasic decline was obtained. At equilibrium, the rate
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in the four phases of the oestrous cycle. Number 
of observations in brackets.
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constants in metoestrus and dioestrus were similar, and 
were significantly lower (p <  O.OOl) than those in proestrus 
and oestrus*
45 2+
3• Ca efflux after removal of ovarian hormonal influence
Since differences in hormonal status clearly influenced
45 2 +
Ca efflux, it was of interest to examine efflux in uteri 
from ovariectomized animals. As in uteri from intact rats,
45 2 +Ca efflux showed a biphasic decline which was similar 
to efflux seen in metoestrus (Fig. 50)« The rate constant
45 2 +of Ca loss was also close to that achieved in metoestrus.
45 2+After 80 minutes of efflux, the residual tissue Ca 
was measured in all uteri and related to their corresponding 
tissue weight (Fig. 51)• The amount of ^^Ca^* retained 
after efflux did not correlate in any way with tissue weight.
4. Effect of SAL on ^^Ca^* efflux in normal and potassium 
chloride depolarized uteri
In order to produce inhibition, adrenoceptor agonists 
could lower the intracellular free Ca concentration by 
increasing Ca^* efflux from the cell. This possibility was
45 2+
investigated by studying the effect of SAL on Ca efflux 
in uteri in oestnrus (oestrogen dominated) and metoestrus 
(progesterone dominated). A concentration of 5 x 10 M SAL 
was used because it produced the maximum inhibitory effect 
in isolated uterine horn preparations. SAL, added during 
the 65-70 minutes period of efflux (Fig. 52), did not alter
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Fig. 51; Residual Ca ^ (expressed as d. p.m./mg wet
weight of tissue) after efflux (filled columns), 
and their corresponding weights (open columns), 
in uteri from the four phases of the oestrous 
cycle, and after ovariectomy. P = proestrus;
0 = oestrus; M = metoestrus; D = dioestrus;
OVX = after ovariectomy. Number of observations 
in brackets.
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Fig. 52; Effect of salbutamol (SAL) on Ca efflux (in 
d.p.m./mg wet weight of tissue against time), 
in the rat isolated uterus in oestrus (A) and 
metoestrus (b ): controls, and in uteri treated 
with potassium chloride (KCl). SAL (5 x 10“^M) 
and KCl (5 x 10“2m ) added between arrows. Numbers 
of observations in brackets.
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43 2+
Ca efflux in oestrus and. in metoestrus.
Since the inhibitory effects of SAL were shown in 
nteri which were contracted with ACh or KCl, a series of 
experiments was performed in which preparations from oestrus 
and metoestrus were depolarized with KCl (5 x 10“^M) which 
was present during the ^0—80 minutes period of efflux.
Neither KCl alone nor SAL in the presence of KCl altered 
efflux (Fig. 32).
43 2 +
5• Ca influx in uteri from the four phases of the oestrous 
cycle and after ovariectomy
Since the ovarian hormones altered ^^Ca^* efflux during 
the oestrus cycle, their possible effects on ^^Ca^^ influx
43 2+were also investigated. Ca influx curves for uteri in 
proestrus, oestrus, metoestrus and dioestrus and in those 
from ovariectomized animals are shown in Figure 33» Saturable 
curves were obtained in the four phases and after ovariectomy. 
At equilibrium, levels of ^^Ca^* uptake in proestrus and 
oestrus were significantly higher (p <  O.OOl) when compared
4 5 2 +to uptake in metoestrus and dioestrus. Ca uptake in 
uteri from ovariectomized animals was significantly lower 
(p <  0 .001) than in any of the phases of the oestrous cycle 
at equilibrium.
6. Effect of SAL on ^^Ca^* influx
As an alternative to efflux, adrenoceptor agonists could 
also lower intracellular free Ca^* concentration by decreasing
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iTiFlux of Ca into the cell* Since SAL did not affect 
efflux, its effects on ^Ca influx were examined in uteri 
from metoestrus and dioestrus* These phases were chosen
45 2 +
because Ca influx was low, and thus it would be easier
to demonstrate changes induced by SAL* SAL (3 x 10”^M)
was present in the Tyrode solution throughout the experiment.
SAL had no statistically significant effect on ^^Ca^* influx
in metoestrus (Fig* 34) and dioestrus (Fig* 35)•
The presence of the ovarian hormones influenced both
43 2+influx and efflux of Ca during the oestrous cycle 
suggesting that the hormones could indirectly affect uterine 
response to the adrenoceptor agonists in this way* However, 
SAL had no effect on either ^^Ca^* influx or efflux in both 
normal and KCl-depolarized uteri* This would suggest that 
adrenoceptor agonists may be lowering intracellular free 
Ca^* concentration by promoting an increase in int ira cellular 
Ca^* binding within its stores*
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DISCUSSION
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A. RESPONSES TO MOTOR AGENTS
ACh produced motor responses in all uteri, i.e., in 
the four phases of the oestrous cycle and in ovariectomized 
animalSj and the ACh potency did not vary under the different 
conditions. Thus , it would appear that the receptor 
population for ACh is constant, and is not influenced by 
the ovarian hormones. However, the maximum tension developed 
in response to ACh varied being highest in oestrus, and 
lowest in ovariectomized animals. As with ACh, uteri from 
oestrus also developed the highest tension to KCl. The 
variations in tension to both ACh and KCl were similar and 
may reflect the observed differences in the thickness of 
the uterine smooth muscle during the oestrous cycle (Digges, 
1980; Boyle & Digges, 1982a).
B. RESPONSES TO ADRENOCEPTOR AGONISTS IN THE OESTROUS CYCLE
All three adrenoceptor agonists — N A , ADR and SAL 
produced inhibitory responses in the four phases of the 
oestrous cycle. Antagonism of the ACh motor response by 
the adrenoceptor agonists is physiological, and is mediated 
through activation of 1^—adrenoceptors (Krall et al «. 1978;
Boyle & Digges, 1982a; Acritopoulou-Fourcroy, Clabaut & 
Schrub, 1985). The rank order of potency of the agonists 
was; ADR >  SAL >  NA for uteri in proestrus, metoestrus and 
dioestrus as reported by other workers, which would suggest
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that the 8-adrenoceptor population is of the 8^-subtype 
(Levy & Apperl'ey, 1978; Johansson, Anders son & Wikberg,
I98O; Nahorski j I98I). However^ in oestrus ^ the rank 
order of potency of the agonists was; ADR >  NA >  SAL, 
suggesting that 8^-adrenoceptors may be present in this 
phase. Oestrus is predominantly under the influence of 
oestrogen (Brenner & West, 1973; Spaziani, 1973) and 
the finding that boili 8^ -^ and 8^-adrenoceptors co-existed 
in an oestrogen dominated rat uterus (Johansson e_t al. ,
I98O; Nahorski, I98I) may explain the above observation.
For each adrenoceptor agonist , both the degree of 
inhibition and the potency varied throughout the oestrous 
cycle. The variation could have been partially due to 
activation of a-excitatory receptors by NA and ADR, thereby 
causing a reduction in their 8-adrenoceptor mediated inhibition. 
At high concentrations, NA and ADR produced small motor 
responses in proestrus and oestrus , which were abolished 
by the a-adrenoceptor antagonist AZA. Similar AZA-sensitive 
motor responses observed in the presence of propanolol 
(Boyle & Digges, 1982a) support the existence of a- 
adrenoceptors in these phases. a—adrenoceptors have been 
demonstrated in the rat uterus during proestrus and oestrus 
by Krall e_t (1978) using the radioligand binding
technique, and by Acritopoulou-Fourcroy e_fc (l983)in in vivo
spontaneously contracting uteri in proestrus. It thus 
appears that a—adrenoceptor activity in the uterus is
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associated with conditions of oestrogen dominance, since 
oestrogen levels are high during proestrus and oestrus 
(Brenner & West, 1973; Spaziani, 1973). In the presence 
of AZA, the maximum degrees of inhibition produced by NA 
(proestrus and oestnis) and ADR (proestrus, oestrus and 
metoestrus) were enhanced. Brooks et (1963) and
Acritopoulou-Fourcroy e_t (1983) reported similar
enhancement of NA and ADR inhibitory effects in the rat 
uterus by a-adrenoceptor antagonists.
At low concentrations, AZA also caused paradoxical 
shifts in ADR dose-response curves to the right. This 
shift may be due to a non-specific excitatory effect of AZA 
independent of a-adrenoceptor antagonism as reported by 
Qayum and Yusuf (1977). Other a-adrenoceptor antagonists 
including phentolamine and tolazoline have also been shown 
to produce similar excitatory effects in the rat uterus 
(Tothill, 1967; Paton, I968). Thus, the rightward shifts 
caused by AZA may be explained on the basis of a non-specific 
stimulant effect.
Notwithstanding the stimulant effect produced by AZA, 
the conclusions can be drawn that there are a-adrenoceptors 
in the rat uterus which subserve an excitatory function. 
However, SAL never produced motor responses and its inhibition 
was unaffected by AZA. Thus, while a-adrenoceptor involvement 
contributed to the variations seen with NA and ADR it 
could not explain the SAL variation.
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The presence of an avid agonist removal mechanism 
into neuronal and extraneuronal tissue (Gillespie, 1973; 
Iversen, 1973; La Bella, I985) would tend to reduce the 
concentration of adrenoceptor agonists at the receptor sites. 
The possibility that these uptake processes may be 
responsible for the variation in uterine response to these 
agonists was investigated in the presence of a neuronal 
uptake inhibitor (DMI) , and an extraneuronal upteike inhibitor 
(NMN). DMI and NMN shifted NA (metoestrus and dioestrus)
ADR and SAL dose-response curves to the left, and enhanced 
the maximum degrees of inhibition. Fleming (l973) and 
Guimaraes and Trendelenburg (1983) described the increased 
sensitivity induced by inhibition of agonists sites of 
loss as deviation supersensitivity. For an agonist that 
is subject to the removal processes, its average concentration 
in the receptor biophase is lower than that in the incubation 
medium. Thus supersensitivity follows when inhibition 
of the sites of loss raises the agonist concentration in 
the biophase (Guimaraes & Trendelenburg, 1983)*
Despite the fact that DMI and NMN shifted agonists 
dose-response curves to the left, corresponding increases 
in their pD^ values were not achieved in all cases. This 
may be due to the fact that in addition to the observed 
leftward shifts, there was an increase in the maximum degrees 
of inhibition produced by the agonists. Thus, changes in 
potency may be occurring, but are concealed by the increased 
intensity of the effect.
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The agonists increased maximum response observed in 
presence of the uptake inhibitors, has also been demonstrated 
in the rat vasa deferentia (Kenakin, I98O, 1984). Kenakin, 
(1984) interpreted the increased maximum response to NA in 
the rat vas deferens in terms of an altered agonist 
concentration gradient within the muscle. Since the rat vasa 
deferentia is a densely innervated tissue, Kenakin’s explanation 
may not be applicable to the rat uterus. The agonists enhanced 
n^aximum degrees of inhibition observed in the present study 
cannot^ therefore, be explained solely on the basis of an 
increased agonist concentration in the receptor biophase. 
Gillespie (1973) proposed that extraneuronally accumulated 
catecholamines may act intracellularly to regulate other 
processes including cell division and smooth muscle motility. 
Because the rat has a sparse adrenergic innervation (Silva 
1966), extraneuronal uptake may be more important than 
neuronal uptake in the disposal of the catecholamines.
Indeed, Boyle and Digges (1982a) found that inhibition of 
the extraneuronal process alone produced effects similar 
to blocking both neuronal and extraneuronal uptake processes.
In the present study, inhibition of the uptake processes 
produced greater effects, i.e., shifts in agonists dose- 
response curves and increases in the maximum degree of 
inhibition, than blockade of the a-excitatory adrenoceptors.
This would suggest that the removal mechanisms play a more 
important role than a-adrenocep tor activity in the observed 
variation in uterine response during the oestrous cycle.
— 188 —
In order to ensure that an effect on 8—adrenoceptors 
uncomplicated by a-adrenoceptor activity and agonist 
removal mechanisms could be obseirved, a series of experiments 
was performed in the presence of AZA , DMI and NMN. The 
combined antagonists shifted N A , ADR (proestrus and oestius) 
and SAL dose—response curves to the left, and enhanced their 
maximum degrees of inhibition. However, in dioestrus, ADR 
dose-response curve was shifted to the right at the lower 
concentrations. This shift may be attributed to the AZA- 
induced non-specific stimulant action as described previously, 
since it was similar to that observed in the presence of 
AZA alone.
The effects produced by the combined antagonists were 
similar to those achieved in the presence of the uptake 
inhibitors alone again supporting the view that agonist 
removal mechanisms are more important than a-adrenoceptor 
activity. However, the variation in uterine response to 
the adrenoceptor agonists persisted even in the presence 
of AZA, DMI and NMN , indicating that other factors may be 
involved.
C. RESPONSES TO ADRENOCEPTOR AGONISTS IN OVARIECTOMIZED ANIMALS
The effects of NA , ADR and SAL were re-examined in 
uteri from animals with bilateral ovariectomy in order to 
assess the influence of the ovarian hormones on their 
inhibitory activity. In contrast to the intact animals
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all three agonists produced complete inhibition of the 
ACh-induced contraction. The rank order of potency of the 
agonists was; SAL >  ADR >  NA. SAL was more potent in 
uteri from ovariectomized animals, than from any phase 
the oestrous cycle in which ADR was the most potent.
It may well be that the 8—adrenoceptor population following 
ovariectomy is predominantly of the 8^-subtype.
The possibility that a-adrenoceptors may also be 
present in uteri from ovariectomized animals was investigated. 
NA and ADR did not produce any motor responses suggesting 
that a-excitatory receptors are absent in this condition.
In the presence of AZA, both ADR and SAL dose-response 
curves were shifted to the right , while the NA curve was 
unaffected. Thus, AZA produced its non-specific excitatory 
effects as in uteri from intact animals.
Since both neuronal and extraneuronal uptake processes 
appeared to play a role in adrenoceptor agonists responses 
during the oestrous cycle , it was of interest to examine 
their effects in uteri from ovariectomized animals. DMI 
and NMN produced classical leftward shifts in NA and ADR 
dose—response curves, while for SAL, only responses to the 
lower concentrations were enhanced. The leftward shifts 
may be ascribed to increased agonist concentrations at 
the receptor sites (Fleming, 1975; Guimaraes & Trendelenburg, 
1983). It thus appears that the removal mechanisms could 
also play a role in adrenoceptor agonists responses in 
uteri from ovariectomized animals.
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To allow comparison with experiments in intact 
animals, the effect of controlling both oc—adrenoceptor 
activity and the uptake processes, was also investigated 
in uteri from ovariectomized rats. In the presence of 
the combined antagonists, the SAL dose—response curve lay 
to the right of its control, while those for NA and ADR 
coincided with the antagonist-free controls. The observed 
rightward shift in the SAL dose-response curve was similar 
to that achieved in the presence of AZA alone. Since both 
SAL and ADR were the most potent in uteri from ovariectomized 
and intact animals respectively, these agonists appeared 
to be more sensitive to the non-specific stimulant effect 
of AZA.
The result of the present study shows that in uteri 
from ovariectomized rats, NA, ADR and SAL produced complete 
physiological antagonism of the ACh-induced contraction.
Thus, the presence of the ovarian hormones during the oestrous 
cycle may underlie the observed variations in uterine 
responses to the adrenoceptor agonists.
One possible explanation as to the mechanism of ovarian 
hormone-induced alteration in uterine response to the 
adrenoceptor agonists may be that the hormones were affecting 
adrenoceptor activity by a direct action on the receptor.
When the maximum degrees of inhibition achieved by NA,
ADR and SAL , in uteri from both intact and ovariectomized 
animals were compared with their potencies at the receptor
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site, no correlation was found. Thus, events responsible 
for the variation in adrenoceptor agonists responses 
the oestrous cycle lay beyond the receptor.
Another explanation may be that the ovarian hormones 
are affecting an intracellular process which in turn 
^ou-ld account for the variation in uterine response to 
the adrenoceptor agonists. The ovainan hormones (especially 
oestrogen) have been reported to increase uterine prostaglandin 
production in the rat uterus (Ham ejt ^., 1975; Sterin-
Speziale e_k ^ . ,  I98O; Wilson, 1983; Gimeno & Gimeno, 1984). 
In consequence» h i ^ e r  levels of endogenous prostaglandins 
would be expected in uteri from rats during the oestrous 
cycle, than fxxjm ovariectomized animals. It thus seems 
that the inability of the adrenoceptor agonists to produce 
complete physiological antagonism of the ACh contraction 
could be partially due to the hormone-dependent high levels 
of prostaglandins during the oestrous cycle.
D. CELLULAR MECHANISMS INVOLVED IN ADRENOCEPTOR AGONISTS 
INHIBITORY RESPONSES
1. Effect of adrenoceptor agonists on intramural prostaglandin 
production
Catecholamines have been shown to stimulate cyclo- 
oxygenase in tissue homogenates and isolated cells (Egan,
Humes & Kuehl, 1978; Bauman, Von Bruchhausen & Wurm , 1979).
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Thus, the present study investigated the possibility that 
by stimulating cyclo-oxygenase, and hence prostaglandin 
biosynthesis in the uterus the adrenoceptor agonists 
could oppose or reduce their own inhibition. The effects 
of the eyelo—oxygenase inhibitor, FBF, were examined under 
two conditions — the first in which only the agonists were 
present (referred to as Control I experiments), and the 
second in which both the agonists and the antagonists AZA,
DMI and NMN were present (referred to as Control II experiments). 
The Control II experiments were performed to ensure that 
an effect on 8-adrenoceptors only, was being examined 
since antagonism of a-adrenoceptor activity, neuronal and 
extraneuronal uptake processes had been shown to modify 
the agonists inhibitory responses.
With some exceptions, FBF shifted NA , ADR and SAL 
Control I and Control II dose-response curves to the left 
and enhanced their maximum degrees of inhibition, such 
that all three agonists produced complete inhibition of 
the ACh contraction. There were corresponding increases in 
agonist potencies, but these did not reach significance 
in all experiments. This failure may be due to the fact 
that in addition to the observed leftward shifts in agonists 
dose-response curves , there was an increase in their 
maximum degrees of inhibition. As observed earlier with 
the uptake inhibitors, changes in potency may be occurring 
but are concealed by the increased intensity of the agonist 
response in the presence of FBF.
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Cyclo-oxygenase inhibition potentiated the inhibitory 
effects produced by all three agonists in the four phases
fLe oestrous cycle. A similar enhancement by indomethacin 
of 8—adrenoceptor mediated relaxation in canine coronary 
arteries has been reported by Rubanyi and Vanhoutte (1983).
It thus appears that in the rat uterus, NA, ADR and SAL, 
may stimulate prostaglandin biosynthesis , and the prosta­
glandins thus formed, would then oppose the 8—adrenoceptor 
mediated relaxation.
The mechanism by which cyclo-oxygenase activity could 
be stimulated by adrenoceptor agonists is not well understood. 
Egan ejb al. (1978) and Bauman e_t al. (l979) have suggested
that the agonists may participate as phenolic cofactors 
for the cyclo-oxygenation of arachidonic acid. It may also 
be possible that stimulation of cyclo-oxygenase could be 
an indirect event evoked by activation of the adrenoceptors. 
Stimulation of a-adrenoceptors has been shown to increase 
prostaglandin generation in the pregnant human myometrium 
(Quaas & Zahradnik, I985; Wikland, Lindblom & Wiqvist,
1985). Thus while a-adrenoceptors may contribute to the 
prostaglandins produced in the rat uterus, the 8-adrenoceptors 
are also important since agonists effects on intramural 
prostaglandin generation persists in the presence of AZA. 
However, the link between adrenoceptor activation, and 
increases in cyclo-oxygenase activity remains to be 
determined. Although both the myometrium and endometrium 
have been demonstrated to generate prostaglandins in the
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rat, the endometrium appears to be the major source 
(Campos ^  , I98O; Brown & Poyser, 1985).
Although NA responses in Control I experiments were 
enhanced by FBF, complete inhibition of the ACh contraction 
was not achieved. Thus , for NA , inhibition of both a- 
adrenoceptor activity and the uptake processes may be 
necessary in order to obtain complete physiological antagonism 
of the ACh-induced contraction in the presence of FBF.
The exceptions to the leftward shift in agonists Control II 
dose-response curves were in metoestrus (NA , ADR and SAL) 
and proestrus (ADR and SAL). It appears that under these 
conditions blocking both a-adrenoceptors and the uptake 
processes may prevent agonists effects on cyclo-oxygenase.
In summary ^ the present results tend to suggest that 
an effect on intramural prostaglandin production could be 
partially responsible for the observed variation in uterine 
response to the adrenoceptor agonists during the oestrous 
cycle. Stimulation of cyclo-oxygenase by the adrenoceptor 
agonists may be achieved in two ways; (a) by a direct 
effect of the agonists on the enzyme, and/or (b) indirectly 
through an effect on adrenoceptors.
In uteri from ovariectomized animals, FBF shifted 
both Control I and Control II dose-response curves for ADR 
and SAL to the left. Just as FBF effects on the NA response 
in Control I experiments were less than in Control II in
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uteri from intact rats, FBF was without effect in Control I 
experiments in uteri from ovariectomized animals, while 
shifting the Control II curve to the left. This would 
suggest that for NA , blockade of both a—adrenoceptor activity 
and the uptake processes may be necessary before an effect 
on cyclo-oxygenase could be demonstrated. The rightward 
shift in the ADR Control II curve at the lower concentrations 
may be attributed to the non-specific excitatory action of 
AZA as described earlier. In general, FBF produced less 
effect in uteri from ovariectomized rats , than in those 
from intact animals. One possible explanation may be that 
since ovarian hormonal influence on uterine prostaglandin 
production was absent in ovariectomized animals , a lower 
basal prostaglandin activity would lead to a reduced FBF— 
induced effect.
In order to ascertain whether cyclo-oxygenase inhibition 
could also modify the responses produced by other uterine 
relaxants, experiments were performed using HIS and PAP.
HIS inhibitory responses in the rat uterus involve activation 
of H^-receptors (Black, Duncan , Durant, Ganellin & Parsons, 
1972; Bertaccini, Molina, Vitali & Zappia, 1979; Ohia & 
Okpako , 1981). Since there is evidence that H^-excitatory 
receptors may also be present in this preparation (Ohia & 
Okpako, 1981), HIS responses were examined in the presence 
of mepyramine. HIS, like the adrenoceptor agonists, 
produced different degrees of inhibition of the ACh—induced
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contraction throughout the oestrous cycle but HIS was 
unaffected by FBF treatment. The non-specific smooth 
muscle relaxant, PAP produced complete inhibition of the 
ACh-induced contraction in proestrus, oestrus, metoestrus 
and dioestrus. This observation demonstrates that it is 
possible to achieve complete physiological antagonism of 
the ACh motor response. As with HIS, FBF treatment had no 
effect on PAP inhibitory responses in the four phases of 
the oestrous cycle. Since neither HIS nor PAP responses 
were modified by FBF ^ the effects produced by eyelo-oxygenase 
inhibition appeared to be specific for adrenoceptor agonists 
NA, ADR and SAL.
Daniel (1982) suggested that drug-induced inhibition 
in smooth muscles which possess no intrinsic tone may be 
influenced differentially by the mechanisms whereby tension 
was increased. Since the rat uterus has no intrinsic tone 
the inhibitory responses to the adrenoceptor agonists have 
been assessed either on spontaneously contracting preparations 
(Rudzik & Miller,1962; Levy & Tozzi, 196]; Pharriss & 
Russell, 1968; Downing & Porter, I98O), or under conditions 
in which tone was induced with 5-hydroxytryptamine (Jensen 
& Vennerod, I961), KCl (Schild, I966, 196?; Diamond & 
Marshall, 1969a ,b; Marshall & Kroeger, 1973), ACh (Ash & 
Schild, 1966; Olsson & Persson, 1971; Vasserman & Levy,
1972; Boyle & Digges^ 1982a, b) and by field stimulation 
(Paterson, I965; Clegg, I966). In order to investigate
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the possibility that the effects produced by FBF was 
not dependent on tone induced with ACh, series of 
experiments were performed using KCl.
KLl produced a biphasic contraction in uteri from the 
four phases of the cycle, as has been reported by other 
workers (Osa & Kuriyama, 1975; Van Breemen, Aaronson & 
Loutzenhiser, 1979). The maintained tension in the 
secondary phase has been associated with an increased 
intracellular free calcium concentration (Bolton, 1979; 
Granger, Hollingworth & Weston , I986). In previous studies^ 
induction of uterine tone with KCl involved replacing sodium 
ions in the bathing medium with equimolar concentrations 
of potassium ions (Van Breemen & Daniel, I966; Marshall & 
Kroeger, 1973; Bengtsson , 1978). Since sodium ions have 
been shown to be necessary for both catecholajnine uptake 
processes (Gillespie, 1973; La Bella, I985) and 
adrenoceptor mediated relaxation of uterine smooth muscle 
(Meisheri & McNeill, 1979b) , KCl-induced tone in the 
present study was achieved by the addition of potassium ions 
to the bathing medium. SAL produced similar effects in 
preparations in which tone was induced with either KCl 
or ACh^ suggesting that the receptors mediating inhibition 
under the two experimental conditions are alike (Schild, 
1967; O'Donnell, Persson & Wanstall, 1978). The combined 
antagonists, i.e., A Z A , DMI and NMN, also potentiated SAL 
inhibitory responses in uteri in which tone was induced 
with KCl.
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As in experiments in which tone was induced with 
ACh, both Control I and Control II type studies were 
performed for SAL in KCl-depolarized preparations. FBF 
shifted both Control I and Control II dose—response curves 
to SAL to the left^ and produced complete relaxation of 
the KCl-induced tone. The effects produced by FBF in 
these experiments were similar to those in which ACh was 
used to induce tone. This would suggest that the effects 
produced by cyclo-oxygenase inhibition were not dependent 
on the motor agent used.
Since arachidonic acid is a precursor of not only the 
prostaglandins^ but also the leukotrienes through lipoxygenase 
activity^ inhibition of cyclo-oxygenase may lead to an 
increased leukotriene formation. Carraher et al. (1983) 
suggested that leukotrienes may also be involved in the 
regulation of uterine motility. The possibility that 
leukotrienes may be affecting the adrenoceptor agonists 
responses was investigated , therefore, in the presence of 
BW 755c ^ an inhibitor of both cyclo-oxygenase and lipoxygenase 
(Rainsford; I985). Control II type experiments were performed 
for SAL in the four phases of the oestrous cycle. BV 755C 
shifted SAL dose—response curves to the left and increased 
SAL potency throughout the oestrous cycle. The effects 
produced by BW 733C were similar to those achieved in the 
presence of FBF suggesting that leukotrienes are not involved 
in the adrenoceptor agonists responses.
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In summary, the results of the present study show 
that adrenoceptor agonists could affect intramural 
prostaglandin production in the rat uterus. The exact 
mechanism responsible for these interactions are unclear 
but they may involve either: (a) a direct action of the 
agonists on cyclo-oxygenase, and/or (b) an indirect action 
on the enzyme via stimulation of adrenoceptors. The 
adrenoceptor agonists appeared to stimulate uterine 
prostaglandin production in the different hormonal conditions 
of the oestrous cycle , and in the absence of the hormones 
following ovariectomy. The effect on prostaglandin 
production was specific since cyclo-oxygenase inhibition 
had no effect on the inhibitory responses to HIS and PAP.
The method of inducing tone appeared to be unimportant 
because cyclo-oxygenase inhibition produced similar effects 
in uteri in which tone was induced with ACh and KCl. The 
effect of cyclo-oxygenase inhibition may be of pharmacological 
importance since adrenoceptor agonists potencies were 
increased in uteri from both intact and ovariectomized 
animals.
Thus , ADR and SAL effects on prostaglandin production 
could be responsible for the observed variation in uterine 
response during the oestrous cycle. An effect on intramural 
prostaglandin generation may partially explain the observed 
variation to NA since, complete inhibition of the ACh 
contraction was achieved only in Control II experiments.
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2. cAMP metabolism
The stimulation of rat uterine P—adrenoceptors by 
agonists has been shown to increase intracellular cAMP 
concentrations (Triner et 1971; Kroeger & Marshall,
1974; Johansson & Andersson, 1978; Meisheri, Diamond & 
McNeill, 1981; Marshall & Fain, 1983). The cAMP concentration 
has also been reported to be elevated in the uterus following 
injection of rats with oestrogen (Szego & Davies, 1967* I969; 
Rosenfeld & O'Malley, 1970; Sandbom et al. » 1973 ; Flandroy 
& Gal and ^  1978; Kishikawa, I98I), and after dji vitro 
treatment of tissues with prostaglandin (Vesin & Harbon, 
1974; Vesin, Do Khac & Harbon, 1978, 1979). It was of
interest, therefore, to investigate the possibility that 
interactions of the adrenoceptor agonists, oestrogen and 
prostaglandins at the level of cAMP metabolism could 
partially account for the differences in uterine response 
to the adrenoceptor agonists during the oestrous cycle.
In the first series of experiments, the possibility 
that changes in cAMP concentrations induced by endogenous 
oestrogen may play a role in the variation in uterine 
response to the adrenoceptor agonists was investigated.
Basal cAMP concentrations were measured in uteri from 
proestrus, oestrus, metoestrus and dioestrus. Uterine 
cAMP content in the four phases were similar suggesting 
that in physiological concentrations , oestrogen does not 
affect basal cAMP production. Since the basal levels
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were similar , the variation in adrenoceptor agonists 
responses might have been due to the differential effect 
of the agonists on cAMP formation. The effect of the P^- 
adrenoceptor agonist, SAL was examined on basal cAMP 
levels in the four phases of the oestrous cycle. The 
concentration of SAL used was that which had produced the 
maximum inhibitory effect in isolated uterine horn 
preparations. SAL caused an approximately seven-fold 
increase in cAMP concentrations over the basal levels, in 
all four phases. It thus appears that the ability of SAL 
to increase uterine cAMP formation via P-adrenoceptor 
activation is unaltered throughout the oestrous cycle.
The variation in the degree of inhibition produced by the 
adrenoceptor agonists cannot, therefore, be attributed to:
(a) effects of endogenous oestrogen on cAMP, and (b) the 
differential effects of the agonists on cAMP formation.
Since exogenous prostaglandin can affect uterine 
cAMP production , experiments were performed to determine 
the possible effects of intramurally generated prostaglandins 
on basal cAMP formation. FBF had no effect on basal cAMP 
levels in the four phases of the oestrous cycle suggesting 
that in physiological concentrations , prostaglandins may 
not affect uterine cAMP production.
Krall ejfc (l984) suggested that exogenous prostaglandin
E^ may antagonize uterine inhibitory responses to P— 
adrenoceptor agonists by a desensitizing action on adenylate
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cyclase. The possibility that prostaglandins generated 
intramurally may have an effect on the ability of SAL 
to increase cAMP levels was, therefore, investigated.
SAL produced similar increases in uterine cAMP concentrations 
over the basal levels , in both the absence, and presence 
of FBF. Thus it would appear that the site of interaction 
between the adrenoceptor agonists and the endogenous 
prostaglandins produced by them^ is not at the level of 
cAMP formation. The results of the present study support 
the view proposed by Harbon and her co-workers (Harbon & 
Clauser, 1971; Vesin & Harbon , 1974) that the excitatory 
effects produced by prostaglandins in the uterus do not 
involve changes in cAMP metabolism. Indeed, only prosta­
glandins of the E series have been shown to affect cAMP 
production in the rat uterus (Bhalla , Sandborn & Korenman, 
1972; Vesin & Harbon^ 1974; Krall £t al., 1984). In 
order to explain the differential effects produced by 
agents acting via cAMP metabolism, Vesin and Harbon (1974) 
and Marshall and Fain (1983), suggested that some form of 
compartmentalization may exist for cAMP in the rat uterus.
cAMP has been reported to induce prostaglandin bio­
synthesis in some tissues including the thyroid (Haye, 
Champion & Jacquemin , 1974),adipose tissue (Feher &
Gidali , 1974) and the adrenal cortex (Laychock , Warner & 
Rubin, 1977). However, results from the present study do 
not support the idea that cAMP formed as a result of
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P-adrenoceptor activation could have directly induced 
rat uterine prostaglandin production. The inhibitory 
responses produced by HIS and PAP were unaffected by 
cyclo-oxygenase inhibition, despite the fact that both 
agents have been shown to increase cAMP levels in this 
tissue (Mitznegg, Schubert & Fuchs, 1975; Bolton, I979).
In summary, basal cAMP levels did not vary significantly 
in the four phases of the oestrous cycle. SAL increased 
uterine cAMP concentrations to the same extent in each 
phase, and the ability of SAL to increase cAMP levels was 
unaffected by cyclo-oxygenase inhibition. Thus the variation 
in adrenoceptor agonists responses throughout the oestrous 
cycle may not involve the differential effects of the 
agonists, oestrogen and intramurally generated prostaglandins 
on uterine cAMP formation.
3• Regulation of intracellular free calcium concentration
The cytoplasmic free calcium concentration which controls 
smooth muscle motility is regulated by three processes - 
influx , efflux and intracellular binding. Previous electro- 
physiological studies by Goto and Csapo (1959), and Marshall 
(1962) showed that oestrogen and progesterone can affect 
calcium movements in the rat uterus. In the present study, 
the possible effects of the hormones on calcium movements 
were examined using radioactive calcium ( ^Ca ) to study 
influx and efflux of this ion in uteri from both intact 
and ovariectomized rats.
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A preliminary series of experiments was performed to 
determine the optimum tracer concentrations to be used 
since the literature revealed a wide range in the ^^Ca^^ 
concentration used by previous workers. For instance , ^^Ca^^ 
concentrations of 4 >iCi/ml (Feinstein, I966) and 1 ^Ci/ml 
(Kroeger, Marshall & Bianchi , 1975) have been used for 
efflux , and 0.01 ^Ci/ml (Hodgson & Daniel, 1973) and 
0.1 |i,Ci/ml (Hodgson, 1976) for influx experiments in the 
rat uterus. Indeed, some workers did not indicate the 
concentration of ^^Ca^^ used in their studies (Van Breemen ^ 
Daniel & Van Breemen, I966; Van Breemen & Daniel, I966; 
Krejci & Daniel, 1970a,b; Batra & Bengtsson, 1978; Batra, 
1982). Uteri from oestrus and metoestrus were used for the 
determination of the optimum tracer concentrations for the 
flux experiments since these phases are under oestrogen 
and progesterone influence respectively (Brenner & Vest, 
1975; Spaziani, 1975). The phases demonstrated a similar
45 2 +
pattern in their concentration-dependent uptake of Ca .
At low tracer concentrations (O.OOO5 - 0.05 v-Ci/ml), tissue 
uptake of ^^Ca^^ reached a plateau which may be attributed 
to the attainment of equilibrium with the bathing medium 
A marked rise in tissue ^^Ca^^ was observed at 
higher tracer concentrations (0.05 — 5 pCi/ml) which may 
be due to appreciable binding in the extracellular space.
A concentration of 2 iiCi/ml was chosen for the
efflux experiments in order to ensure adequate loading of 
the cells and their extracellular compartment. For influx
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experiments, a concentration of 0.25 ]xC±/ml was used so 
as to reduce the non-specific binding of tracer in the 
extracellular compartment.
45 2 +
Ca efflux from uteri in the four phases of the
oestrous cycle and from ovariectomized animals , exhibited
a biphasic pattern of decline. The initial rapid phase of
decline represented ^^Ca^* loss mainly from the extracellular
space, while the secondary slower phase showed loss from
more firmly bound intracellular sites. Similar biphasic
curves have been demonstrated by other workers in uteri
from rats pretreated with oestrogen and progesterone (Van
Breemen ejt ad. , I966; Krejci & Daniel , 1970 a, b) and those
from late pregnancy (Kroeger e_t ad• , 1975). After 50
4 "n 2+minutes, the efflux of Ca slowed down considerably in
all tissues indicating that equilibrium was being approached.
Uteri from proestrus, oestrus and dioestrus released more 
45 2 +Ca into the bathing medium than did those from metoestrus 
45 2 +Ca efflux in uteri from ovariectomized animals was 
similar to that in metoestrus.
However, when the rate constants for ^Ca loss (i.e. 
^^Ca^* leaving tissue during collection interval divided 
by the ^^Ca^'*’ in the tissue before collection interval) 
were compared after 5C minutes, uteri from proestrus and 
oestnis had similar values which were higher than those 
from metoestrus, dioestrus and ovariectomized animals. The 
finding that the rate constants of ^Ca loss in uteri
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from metoestrus and dioestrus were smaller would tend 
to support the hypothesis that calcium may be more firmly 
bound under progesterone influence (Goto & Csapo, 1939; 
Marshall, I962). The rate constants of ^^Ca^ '*’ loss in 
uteri devoid of the ovarian hormonal influence were found 
to be similar to those under progesterone dominance. Thus 
it would appear that oestrogen rather than progesterone 
may be responsible for the changes in ^^Ca^* efflux in 
the rat uterus. Marshall (1962) suggested that myométrial 
cells under the influence of oestrogen may be freely 
permeable to calcium ions.
In order to determine whether the observed variation
43 2 +in Ca efflux might have been due to ovarian hormone-
induced changes in the size of the uterus ^ the residual 
45 2 +Ca in each tissue was measured at the end of efflux 
experiments. No correlation was found between the residual 
^^Ca^'*’ in tissues and the corresponding tissue weights in 
uteri from both intact and ovariectomized animals. Thus 
the observed variation in ^^Ca^^ efflux is specific , and 
is not dependent on the morphology of the uterus. The 
finding that ^^Ca^^ was retained in the tissues after the 
efflux experiments would tend to suggest that there may be 
sites of ^^Ca^^ sequestration which are not readily available 
for exchange. These uterine ^Ca stores appeared to vary 
during the oestrous cycle and in ovariectomized animals.
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One way in which P-adrenoceptor agonists could reduce
cytoplasmic free calcium concentration would be via increased
©fflux of this ion from the cell* This possibility was
investigated using SAL , at a concentration which had
produced the maximum inhibitory effect in isolated uterine
horn preparations. SAL had no effect on efflux
in uteri from oestrus and metoestrus. Feinstein (1966)
also found that ADR did not alter ^^ Ca^ '*' efflux in the rat
uterus. Since SAL inhibitory responses in isolated uterine
horn preparations were examined under conditions of induced
tone, a series of experiments was performed in which KCl
(50 mM) was present after 50 minutes of efflux. SAL also
had no effect on ^^Ca^* efflux in KCl-depolarized uteri
from oestnrus and metoestrus. In these experiments, KCl
hr. 2 +
alone did not alter Ca efflux. Similar results were
obtained by Krejci and Daniel (l970a) in uteri from oestrogen
45 2 +
pretreated rats. Failure of KCl to affect Ca efflux 
was surprising since KCl depolarization has been shown to 
involve an influx of calcium into the cell (Batra, 1985;
Granger ^  ^ .  , I986). The influx of extracellular calcium 
might have been expected to displace ^Ca from the cell 
and hence increased ^^Ca^* efflux. Van Breemen and Daniel 
(1966) demonstrated an increased ^Ca efflux in the 
presence of KCl , in uteri from oestrogen pretreated immature 
rats. However, these workers used a much higher concentration
45 2 +
of KCl (191 mM) and did not observe any effect on Ca
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efflux before the 120 minutes period. In the present 
study and that reported by Krejci and Daniel (1970a)
KCl was added before the 120 minutes period and this, could 
explain the inability to observe an effect on ^^Ca^^ efflux. 
The effect of KCl on ^Ca efflux in smooth muscles other 
than the uterus is also controversial (Bolton, I979).
In summary, the ovarian hormone, oestrogen appeared to 
promote an increased efflux of ^^Ca^* from the rat uterus 
during the oestrous cycle. SAL had no effect on ^^Ca^* 
efflux in both normal and KCl-depolarized uteri, suggesting 
that the adrenoceptor agonists may not be reducing cytoplasmic 
free calcium concentration by increasing calcium efflux. 
Alternatively , the inability to demonstrate an effect on 
efflux by the adrenoceptor agonists may be due to the 
retention of ^^Ca^* within the extracellular space which
45 2 +
would tend to obscure the smaller cellular efflux of Ca 
(Spaziani, 1975).
Since the presence of the ovarian hormones did affect 
^^Ca^+ efflux as seen from the differences in uteri from 
both intact and ovariectomized animals , it was of interest
45 2+
to investigate hormonal effects on Ca influx. In
45 2 +
uteri from both intact and ovariectomized rats, Ca 
influx was biphasic with an initial rapid phase , followed 
by a slower phase which eventually reached a plateau.
At equilibrium, influx of was higher in uteri from
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oestrus and proestrus, than in those from metoestrus and 
dioestrus• Similar observations have been made in uteri 
from rats pretreated with oestrogen and progesterone 
(Van Breemen et , I 9 6 6 ;  Batra & Sjogren^ 1 9 8 3 ) .  
influx in uteri from ovariectomized rats was less than 
in those from intact animals suggesting a role for the 
ovarian hormones in the regulation of calcium entry into 
the cell. Thus, oestrogen and progesterone may alter the 
ionic permeability of the membrane which could lead to an 
increased calcium influx into the cell. However, the 
precise mechanism responsible for the hormone-induced 
changes in calcium permeability is unclear.
P-adrenoceptor agonists could lower cytoplasmic free
calcium concentration via a reduction of its influx into
Zi c; 2+
the cell. The effect of SAL on ^Ca influx was, therefore, 
investigated in uteri from animals in metoestrus and dioestrus 
As described above, the concentration of SAL used in these 
experiments produced the maximum inhibitory effect in 
isolated uterine horn preparations. Metoestrus and dioestrus
45 2+
phases were chosen since the degree of Ca influx was 
lower than those in proestrus and oestrus^ and thus SAL 
induced changes may be more easily observed. SAL did not 
affect ^^Ca^* influx in these phases suggesting that it 
was unlikely that P-adrenoceptor mediated inhibition 
involved a reduced calcium influx into the cell. Hodgson
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(1976) also found that isoprenaline had no effect on
45 2+ .
Ca influx in the rat uterus during late pregnancy.
4 5 2 +
In summary^ Ca efflux and influx varied in uteri 
from proestrus, oestrus^ metoestns and dioestrus with 
flnxes generally higher in oestrogen than in progesterone 
dominated phases. ^Ca efflux in uteri from ovariectomized 
animals was similar to those in the metoestrus phase of 
the oestrous cycle. In contrast influx in uteri
from ovariectomized rats was lower than in those from
intact animals. Thus, the mechanism responsible for the
4 5 2 +altered Ca fluxes may be complex, since efflux appeared
to be controlled mainly by oestrogen, while influx could
be regulated by both oestrogen and progesterone. SAL had
4 5 2 +no effect on either Ca efflux or influx.
The observation that ovarian hormones play a role in 
calcium movements in the rat uterus merits further investi­
gation. Recently, Batra (l9&5) showed that KCl—stimulated 
^^ Ca^ '*' influx in myometrium from oestrogen pretreated rats 
was inhibited by calcium channel blockers, nitrendipine 
and D-600. However, there was no correlation between the 
action of D-6OO on ^^Ca^+ influx and its inhibitory effect 
on —nitrendipine binding, suggesting that calcium
channels in the myométrial membranes may possess multiple 
sites. It is therefore possible that the ovarian hormones 
may act at different sites on membrane calcium channels to
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regulate efflux and influx of calcium ions into the cell.
The altered calcium fluxes in uteri during the oestrous 
cycle could result in differences in the cytoplasmic free 
calcium concentration in each phase. Thus, ovarian hormone- 
induced changes in calcium function may be partially 
responsible for the observed variation in uterine response 
to the adrenoceptor agonists. As a consequence of their 
effects on calcium movements , the ovarian hormones may also 
be involved in the maintenance of uterine tone.
However^ interpretation of results from radiolabelled 
ion flux experiments requires caution, since factors 
responsible for their movements are unclear. The fluxes 
of ions into, or from smooth muscle cells may be determined 
both by their permeability (i.e., the existence of ion 
channels) p and by the activity of carrier molecules in the 
membrane (Bolton^ 1979). There are two factors which may
4.5 2 +
complicate interpretation of data when using Ca to 
study calcium movements; (a) appreciable binding of the 
ion to extracellular sites, (b) existence of intracellularly 
bound calcium in the mitochondria, endoplasmic reticulum 
or other cell organelles. The non-specific binding of 
tracer calcium may be of such magnitude as to obscure 
subtle changes induced by agents (Van Breemen, Farinas, 
Casteels, Gerba, Wuytack & Deth, 1973» Bolton, 1979).
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SAL had no effect on fluxes in this study
and this would- support the hypothesis that P-adrenoceptor 
mediated inhibition could be the consequence of an increased 
intracellular calcium binding (Mueller & Van Breemen, 1979» 
Kamm & Stull, I985). This increased binding would lead to 
a reduction in the concentration of free calcium ions in 
the cytoplasm. However, controversy exists regarding 
the main site of calcium sequestration in uteri from 
different species (Carsten, I969; Batra, 1972, 1973). In 
the rat; both the plasma membrane (Rangachari, Pemollet & 
Worcel, 1976) and sarcoplasmic reticulum (Krall, Swensen 
& Korenman , 1976; Chaturvedi, Fox , Rama Sastry. & Land on, 
1979) have been shown to be major sites of calcium binding.
In conclusion, the observed variation in uterine 
response to the adrenoceptor agonists during the oestrous 
cycle is due to the effect of several factors on the response 
mechanisms. At the P-adrenoceptor site , agonist uptake 
processes, and to a lesser extent a-adrenoceptor activity 
(for combined a- and P-agonists) contributed to the variation 
in response. Blockade of the uptake processes increased 
both the potency and the maximum degree of inhibition 
produced by the agonists suggesting that effects on other 
cellular processes could also be involved in the observed 
variation in response. Ovariectomy enhanced the adrenoceptor 
agonists inhibitory responses suggesting a role for the
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ovarian hormones mediated via an intracellular mechanism. 
Agonists effect on intramurally generated prostaglandins 
could also be involved in the observed variation since 
cyclo-oxygenase inhibition increased both agonist potency 
and the maximum degree of inhibition. cAMP metabolism 
did not appear to play a role because adrenoceptor agonist 
effects on cAMP formation was unaltered in the four phases. 
Ovarian hormones do affect calcium movements into, and out 
of uterine cells and thus may control the intracellular 
free calcium concentration. In this way, the ovarian 
hormones could alter the calcium environment in which cAMP 
operates.
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ADDENDUM
The time courses for the inhibitory effects produced by 
the adrenoceptor agonists and PAP and HIS were determined in 
preliminary experiments using uteri from rats in oestrus and 
metoestrus. ACh was used to induce tone in each preparation 
as described previously (See Methods 0.1(a)). After obtaining 
the standard submaximal response to ACh, the Tyrode solution 
was changed to one containing the inhibitory agonist. The 
standard ACh dose was then added after 30 seconds, and there­
after at 1 minute intervals until a constant response was 
achieved in the presence of the agonist. The times required 
for the maximal inhibitory effect of the agonists were; (a) 
adrenoceptor agonists, 30 seconds, (b) PAP, 1 minute and (c)
HIS, 2 minutes.
Similar time courses were reported by Marshall & Kroeger 
(1973) for the effects of isoprenaline and PAP in the rat uterus 
These workers also found that the time course for the increase 
in cAMP produced by both agents correlated with that for 
relaxation. On the basis of the preliminary experiments
described above and the work of Marshall and Kroeger (l973)»
!
it was decided that the maximal effect of adrenoceptor agonists 
on the rat isolated uterus could be achieved within 30 seconds. 
However, in some smooth muscles the time course for effects 
on P-adrenoceptors may be longer period than 30 seconds since 
equilibration at the P-receptor site required several minutes 
(Sir J.W. Black, personal communication). If indeed a longe, 
time course was required for the full development of the
;r
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inhibitory effect of the adrenoceptor agonists in the rat 
uterus, any factor altering the time scale of their action 
would affect the measurements which were made in the early 
phase of the response and thus, could influence interpretation 
of the observed changes in uterine response to the adrenoceptor 
agonists.
APPENDIX
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Fig. 56: Schematic representation of processes
involved in catecholamine inhibitory 
responses in the rat uterus. Solid lines = 
known pathways; broken lines = hypothetical 
pathways. Stimulation of cyclo-oxygenase 
by catecholamines may be achieved either by 
a direct effect on the enzyme, and/or by an 
indirect action via stimulation of adrenoceptors 
Ovarian hormones appear to alter intracellular 
free calcium levels by an effect on calcium 
movements.
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THE EFFECTS OF UPTAKE ME CHAN ISM S AND ALPHA RECEPTOR 
ACTIVITY ON RAT UTERINE RESPONSE TO CATECHOLAMINES.
F.C. Boyle C S.E. Ohia, D e part men t of Pharmacology,
Glasgow University, G12 8QQ, U.K.
The importance of ca tech o l a m i n e  uptake processes and/or 
a - r e c e p t o r  activity to the overall response of the isolat­
ed rat uterus to n o r a d r e n a l i n e  (NA), adrenaline (ADR) and 
salbutamol (SAL) have been studied throughout the oestrous 
cycle. Uptake^ and Uptake; were blocked with desipramine 
(DMI) (10~®M) and no rmet a n e p h r i n e  (NMN) (10 *M) r e spec tiv­
ely, whilst a - r e c e p t o r  activi ty was bl ocked with azapetine 
(AZA) (10 *M). AZA po ten t i a t e d  the ma ximum degree of 
inhibition produced by NA (proestrus and oestrus only),
SAL (oestrus only) and ADR in all stages of the cycle.
DMI and NMN shifted the NA, SAL and ADR dose response 
curves to the left th roug hou t the cycle. AZA, in co m b i n ­
ation with DMI and NMN pr oduc ed further po tent iat ions of 
the NA curves in p r oest rus and oestrus only, but had no 
effect on NA, SAL and ADR responses in the other stages. 
Both NA and ADR (10 *M-3xlO *M) pr oduc ed small motor 
responses in pr oes t r u s  and oestrus which were abolished 
by AZA (10 *M). Bl ocka de of either uptake and/or o- 
receptor activi ty pr o d u c e d  si gnificant changes in P D 2 
values for the 3 amines in the 4 stages of the cycle. The 
a^ove ex periments show that both uptake mechanisms and a- 
r except or activity should be controlled when assessing 
uterine response to c a t e c h o l a m i n e s . However, the import­
ance of each factor varies with the amine.
British Journal of Pharmacology. 84. 42P.
CHANGES IN CATECHOLAMINE INHIBITORY EFFECTS IN THE RAT ISOLATED 
UTERUS INDUCED BY OVARIECTOMY AND CYCLO-OXYGENASE INHIBITION
F.C. Boyle & S.E. Ohia*, Department of Pharmacology, University of Glasgow,
Glasgow G12 8QQ
Catecholamine induced relaxation of rat uterus is mediated mainly through 6- 
adrenoceptors (Boyle & Digges, 1982), but B-adrenoceptor agonists produce differ­
ent degrees of inhibition throughout the oestrous cycle in both controls and in 
uteri in which a-adrenoceptors and catechol amine-removal processes are blocked 
(Boyle & Ohia, 1984). The mechanisms underlying these differences are unclear.
Two possible explanations lie in the presence of the ovarian hormones and the 
generation of prostaglandins within the tissue (Gimeno & Gimeno, 1984). The 
present study was designed to examine the roles of the hormones and prostaglandins, 
by investigating adrenoceptor agonist activity in ovariectomized rats and in rats 
after treatment with the cyclo-oxygenase inhibitor flubiprofen (FBF) to inhibit 
prostaglandin synthesis.
Virgin female untreated (180-250g) and ovariectomized (200-260g) Wistar rats were 
used. The four phases of the oestrous cycle were identified from vaginal smears. 
2-3cm lengths of each uterine horn were set up in paired 10ml organ baths contain­
ing Tyrodes solution at 37®C and gassed with 95% 0 2 /6% CO 2 . Since the rat uterus 
has no intrinsic tone, inhibitory responses to adrenoceptor agonists and to the 
smooth muscle relaxant papaverine (PAP) were measured as the percentage inhibition 
of sub-maximal (60-70%) acetylcholine (ACh)-induced contractions, measured iso- 
metrical ly. The agonists were added to the organ baths 30s before addition of ACh. 
FBF (10"‘M), added to the Tyrodes solution, was in contact with the tissue for at 
least 30 min before addition of ACh. FBF had no effect on the response to ACh in 
either control or ovariectomized rats.
Noradrenaline (NA), adrenaline (ADR) and salbutamol (SAL), each produced a dose 
dependent inhibition of ACh in both control (NA 10“*-10"*M; ADR 10T''-10"'M; SAL 
5xlO"*-SxlO"‘M) and in ovariectomized rats (NA 3x10"*‘-lO^'M; ADR 10"**-3xlO'*M;
SAL 5x10"**-5xlO"*M) but in the latter, the effects of the amines were enhanced 
significantly (e.g. in metoestrus phase, % maximal inhibition of ACh for NA is 
44.6±5.4, n=6 whilst in ovariectomized rats, it is 100±0.0, n«6 . P < 0.001) and 
each amine consistently abolished the ACh-induced contraction.
FBF treatment also enhanced significantly the effects of the three amines in 
untreated rats and each amine again abolished ACh contractions. FBF shifted the 
dose-response curve of each amine to the left in both untreated and ovariectomized 
rats.
In contrast to the adrenoceptor agonists PAP (3xl0"'-10"'M) inhibited ACh induced 
contractions completely in all stages of oestrous and was unaffected by FBF.
These results show that removal of ovarian hormones and inhibition of prostaglandin 
synthesis enhance B-adrenoceptor agonist inhibitory effects and suggest that the 
presence of ovarian hormones and prostaglandin generation underlie the differences 
observed in the inhibitory effects of NA, ADR and SAL. The site and mechanism of 
the interaction is not known, but the effectiveness of PAP in inhibiting ACh con­
tractions is consistent with an intracellular mechanism which is also linked with 
adrenoceptor activation.
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SPECIFICITY OF ENHANCEMENT OF SALBUTAMOL RESPONSES BY CYCLO- 
OXYGENASE INHIBITION IN THE RAT ISOLATED UTERUS
F.C. Boyle & S.E. Ohia*, Department of Pharmacology, University of Glasgow,
Glasgow G12 8QQ
Inhibition of acetylcholine (ACh)-induced tone in the rat uterus by g-adrenoceptor 
agonists is enhanced after cyclo-oxygenase blockade (Boyle & Ohia, 1985). The 
inhibition produced by relaxants in smooth muscles which possess no intrinsic tone 
may be influenced differentially by the mechanisms whereby tension is increased 
(Daniel, 1982). The cyclo-oxygenase substrate arachidonic acid is also a sub­
strate for lipoxygenase, and products from this pathway may be involved in uterine 
motility (Carraher, Hahn, Ritchie & McGuire, 1983). Thus this study investigated 
whether the enhancement of 6-adrenoceptor responses seen after cyclo-oxygenase 
inhibition was dependent on the motor agent used and whether lipoxygenase inhib­
ition affected the relaxations in the four phases of the oesJ:rous cycle.
Virgin female Wistar rats weighing (180-250g) were used and the preparation was 
set up as described previously (Boyle & Ohia, 1985). Tone was induced with either 
ACh or potassium chloride (KCl, 5xlO"2M). Since KCl produced a biphasic contract­
ion with an initial transient phase and a secondary sustained phase lasting for 
more than one hour, cummulative dose response curves were constructed to the 
relaxants 15 min into the sustained phase until maximum inhibition of the KCl- 
induced tone was obtained. The cyclo-oxygenase inhibitor, flurbiprofen (FBF, 
10"6m ), and the inhibitor of both cyclo-oxygenase and lipoxygenase, BW 755C 
(10~5m ), when used, were present in the Tyrodes solution and had no effect on KCl 
or ACh responses.
As with ACh-induced contractions, salbutamol (SAL, 1.5xlO“l 1-5x10 ”6m ) produced dose 
dependent relaxations of KCl-induced tone in proestrus, oestrus, metoestrus and 
dioestrus. FBF increased SAL inhibitory responses and produced a significant 
shift in the dose response curves to the left. For instance in proestrus, SAL pD« 
values were increased significantly from 9.77+0.30, n=6 before, to 10.66+0.09, 
n=6 (P<0.01) after FBF.
BW 755C enhanced SAL relaxation of KCl-induced tone and shifted dose response 
curves to the left to the same degree as occurred with FBF.
When inhibition of ACh-induced tone was produced by histamine acting via H«- 
receptors (HIS, 10^7-10-4%, in the presence of H,-receptor antagonist mepyramine, 
5x 10"8m ), FBF produced no enhancement in any phase of the oestrous cycle.
The FBF enhancement of SAL inhibition in uteri stimulated with both KCl and ACh 
suggests that its effect is not dependent on the motor agent used. Since BW 755C 
had no greater effect than FBF, it is likely that products of the lipoxygenase 
pathway were not involved in 6-adrenoceptor mediated relaxation. Inhibition 
induced by stimulating HIS Hp-receptors was not affected by FBF and therefore 
enhancement of SAL responses is specific to 6-adrenoceptor activation. The 
hormonal state of the animal did not appear to be of major importance because the 
same effects were observed in all four phases of the oestrous cycle. Rubanyi & 
Vanhoutte (1985) reported similar potentiation of e-adrenoceptive mechanisms by 
cyclo-oxygenase inhibition in vascular smooth muscle.
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